<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK201366" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK201366/" /><meta name="ncbi_pagename" content="TRPV4-Associated Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>TRPV4-Associated Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="TRPV4-Associated Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/05/15" /><meta name="citation_author" content="Alice Schindler" /><meta name="citation_author" content="Charlotte Sumner" /><meta name="citation_author" content="Julie E Hoover-Fong" /><meta name="citation_pmid" content="24830047" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK201366/" /><meta name="citation_keywords" content="Metatropic Dysplasia" /><meta name="citation_keywords" content="CMT2C" /><meta name="citation_keywords" content="Autosomal Dominant Brachyolmia" /><meta name="citation_keywords" content="Spondylometaphyseal Dysplasia, Kozlowski Type" /><meta name="citation_keywords" content="Scapuloperoneal Spinal Muscular Atrophy" /><meta name="citation_keywords" content="Congenital Distal Spinal Muscular Atrophy" /><meta name="citation_keywords" content="Familial Digital Arthropathy-Brachydactyly" /><meta name="citation_keywords" content="Spondyloepiphyseal Dysplasia, Maroteaux Type" /><meta name="citation_keywords" content="Parastremmatic Dysplasia" /><meta name="citation_keywords" content="Transient receptor potential cation channel subfamily V member 4" /><meta name="citation_keywords" content="TRPV4" /><meta name="citation_keywords" content="TRPV4-Associated Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="TRPV4-Associated Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Alice Schindler" /><meta name="DC.Contributor" content="Charlotte Sumner" /><meta name="DC.Contributor" content="Julie E Hoover-Fong" /><meta name="DC.Date" content="2014/05/15" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK201366/" /><meta name="description" content="The TRPV4-associated disorders (previously considered to be clinically distinct phenotypes before their molecular basis was discovered) are now grouped into neuromuscular disorders and skeletal dysplasias; however, the overlap within and between both groups is considerable. Bilateral progressive sensorineural hearing loss (SNHL) can occur in both." /><meta name="og:title" content="TRPV4-Associated Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="The TRPV4-associated disorders (previously considered to be clinically distinct phenotypes before their molecular basis was discovered) are now grouped into neuromuscular disorders and skeletal dysplasias; however, the overlap within and between both groups is considerable. Bilateral progressive sensorineural hearing loss (SNHL) can occur in both." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK201366/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cmt2c/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK201366/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89F52EDFC84FB100000000085A03DB.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK201366_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK201366_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/trio-id/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pc-hypo-p/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK201366_"><span class="title" itemprop="name"><i>TRPV4</i>-Associated Disorders</span></h1><p class="contrib-group"><span itemprop="author">Alice Schindler</span>, MS, CGC, <span itemprop="author">Charlotte Sumner</span>, MD, and <span itemprop="author">Julie E Hoover-Fong</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK201366_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK201366_ai__"><div class="contrib half_rhythm"><span itemprop="author">Alice Schindler</span>, MS, CGC<div class="affiliation small">National Institute of Neurological Disorders and Stroke, Neurogenetics Branch<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@bareldnihcs" class="oemail">vog.hin.liam@bareldnihcs</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Charlotte Sumner</span>, MD<div class="affiliation small">Department of Neurology<br />Johns Hopkins Hospital<br />Baltimore, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.imhj@1renmusc" class="oemail">ude.imhj@1renmusc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Julie E Hoover-Fong</span>, MD, PhD<div class="affiliation small">Department of Pediatrics &#x02013; Genetic Medicine<br />Johns Hopkins Hospital<br />Baltimore, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.imhj@2revoohj" class="oemail">ude.imhj@2revoohj</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 15, 2014</span>.</p><p><em>Estimated reading time: 28 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cmt2c.Summary" itemprop="description"><h2 id="_cmt2c_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The <i>TRPV4</i>-associated disorders (previously considered to be clinically distinct phenotypes before their molecular basis was discovered) are now grouped into neuromuscular disorders and skeletal dysplasias; however, the overlap within and between both groups is considerable. Bilateral progressive sensorineural hearing loss (SNHL) can occur in both.</p><p>The three neuromuscular disorders (mildest to most severe):</p><ul><li class="half_rhythm"><div>Charcot-Marie-Tooth disease type 2C (CMT2C)</div></li><li class="half_rhythm"><div>Scapuloperoneal spinal muscular atrophy (SPSMA)</div></li><li class="half_rhythm"><div>Congenital distal spinal muscular atrophy (CDSMA)</div></li></ul><p>The neuromuscular disorders are characterized by a progressive peripheral neuropathy with variable combinations of laryngeal dysfunction (i.e., vocal fold paresis), respiratory dysfunction, and joint contractures.</p><p>The six skeletal dysplasias:</p><ul><li class="half_rhythm"><div>Mildest:</div><ul><li class="half_rhythm"><div>Familial digital arthropathy-brachydactyly</div></li></ul></li><li class="half_rhythm"><div>Intermediate:</div><ul><li class="half_rhythm"><div>Autosomal dominant brachyolmia</div></li><li class="half_rhythm"><div>Spondylometaphyseal dysplasia, Kozlowski type</div></li><li class="half_rhythm"><div>Spondyloepiphyseal dysplasia, Maroteaux type</div></li></ul></li><li class="half_rhythm"><div>Most severe:</div><ul><li class="half_rhythm"><div>Parastremmatic dysplasia</div></li><li class="half_rhythm"><div>Metatropic dysplasia</div></li></ul></li></ul><p>The skeletal dysplasia is characterized by brachydactyly (in all 6); the five that are more severe have short stature that varies from mild to severe with progressive spinal deformity and involvement of the long bones and pelvis. In the mildest of the <i>TRPV4</i>-associated disorders life span is normal; in the most severe it is shortened.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>TRPV4</i>-associated disorders is based on clinical and neurophysiologic findings, radiographic findings in the skeletal dysplasias, and the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>TRPV4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment is symptomatic. Affected individuals are often evaluated and managed by a multidisciplinary team that includes neurologists, physiatrists, orthopedic surgeons, and physical and occupational therapists. SNHL is managed by specialists to determine the best habilitation options.</p><p>For neuromuscular disorders: Neuropathy and respiratory dysfunction are managed in a routine manner; laryngeal dysfunction requires speech therapy and, in some instances, surgery.</p><p>For skeletal dysplasias: Physical therapy/exercise to maintain function; surgical intervention when kyphoscoliosis compromises pulmonary function and/or causes pain and/or when upper cervical spine instability and/or cervical myelopathy are present.</p><p><i>Surveillance:</i> For neuromuscular disorders: Routine neurologic examinations, physical therapy assessments, monitoring of laryngeal function, respiratory function, and hearing. For skeletal dysplasias: Annual evaluation for joint pain and scoliosis; assessment for odontoid hypoplasia before a child reaches school age and before surgical procedures involving general anesthesia.</p><p><i>Agents/circumstances to avoid:</i> For neuromuscular disorders: Obesity as it makes walking more difficult; medications that are toxic or potentially toxic to persons with a peripheral neuropathy. For skeletal dysplasias: Extreme neck flexion and extension (in those with odontoid hypoplasia); activities that place undue stress on the spine and weight-bearing joints.</p><p><i>Pregnancy management:</i> Ideally a woman with <i>TRPV4</i>-associated disorder would seek consultation from a high-risk OB/GYN or maternal-fetal-medicine specialist to evaluate risk for pregnancy and delivery.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>TRPV4</i>-associated disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Most individuals diagnosed with a <i>TRPV4</i>-associated disorder have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. However, since the most severe skeletal phenotypes can be lethal in childhood (or in utero), children with these phenotypes likely have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and unaffected parents. Each child of an individual with a <i>TRPV4</i>-associated disorder has a 50% chance of inheriting the pathogenic variant. Specific <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, age of onset, and disease severity cannot be predicted accurately because of incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a>. However, in general, a child who inherits a <i>TRPV4</i> pathogenic variant associated with neuromuscular disease or skeletal dysplasia from an affected parent is likely to have the same phenotype as the parent. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant has been identified in an affected family member.</p></div></div><div id="cmt2c.GeneReview_Scope"><h2 id="_cmt2c_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="cmt2c.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK201366/table/cmt2c.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2c.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cmt2c.Tc_1_1_1_1" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"><i>TRPV4</i>-Associated Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_cmt2c.Tc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neuromuscular disorders</b></td><td headers="hd_h_cmt2c.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Charcot-Marie-Tooth neuropathy type 2C</div></li><li class="half_rhythm"><div>Scapuloperoneal spinal muscular atrophy</div></li><li class="half_rhythm"><div>Congenital distal spinal muscular atrophy</div></li></ul></td></tr><tr><td headers="hd_h_cmt2c.Tc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Skeletal dysplasias</b></td><td headers="hd_h_cmt2c.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Familial digital arthropathy-brachydactyly</div></li><li class="half_rhythm"><div>Autosomal dominant brachyolmia</div></li><li class="half_rhythm"><div>Spondylometaphyseal dysplasia, Kozlowski type</div></li><li class="half_rhythm"><div>Spondyloepiphyseal dysplasia, Maroteaux type</div></li><li class="half_rhythm"><div>Parastremmatic dysplasia</div></li><li class="half_rhythm"><div>Metatropic dysplasia</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#cmt2c.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="cmt2c.TF.c.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#cmt2c.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="cmt2c.Diagnosis"><h2 id="_cmt2c_Diagnosis_">Diagnosis</h2><p>The phenotypes associated with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>TRPV4</i> pathogenic variants were considered to be clinically distinct disorders long before their molecular basis was discovered. Now with the current understanding of their molecular basis, these <i>TRPV4</i>-associated disorders have been grouped primarily into neuromuscular disorders and skeletal dysplasias; however, the overlap within the neuromuscular disorders and within the skeletal dysplasias is considerable &#x02013; as may be the overlap between the neuromuscular disorders and the skeletal dysplasias. Of note, bilateral progressive sensorineural hearing loss (SNHL) that ranges from mild to moderate can occur in both. Thus, <i>TRPV4</i>-associated disorders comprise a continuum that precludes the establishment of clear distinctions within and between phenotypes.</p><p>The phenotypes comprising the two groups of <i>TRPV4</i>-associated disorders (listed from mildest to most severe) are:</p><ul><li class="half_rhythm"><div>Neuromuscular disorders (see <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.neurologic_findings_by_trpv4asso/?report=objectonly" target="object" rid-figpopup="figcmt2cTneurologicfindingsbytrpv4asso" rid-ob="figobcmt2cTneurologicfindingsbytrpv4asso">Table 1</a>):</div><ul><li class="half_rhythm"><div>Charcot-Marie-Tooth disease type 2C</div></li><li class="half_rhythm"><div>Scapuloperoneal spinal muscular atrophy</div></li><li class="half_rhythm"><div>Congenital distal spinal muscular atrophy</div></li></ul></li><li class="half_rhythm"><div>Skeletal dysplasias (see <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.radiographic_and_clinical_featur/?report=objectonly" target="object" rid-figpopup="figcmt2cTradiographicandclinicalfeatur" rid-ob="figobcmt2cTradiographicandclinicalfeatur">Table 2</a>):</div><ul><li class="half_rhythm"><div>Familial digital arthropathy-brachydactyly</div></li><li class="half_rhythm"><div>Autosomal dominant brachyolmia</div></li><li class="half_rhythm"><div>Spondylometaphyseal dysplasia, Kozlowski type</div></li><li class="half_rhythm"><div>Spondyloepiphyseal dysplasia, Maroteaux type</div></li><li class="half_rhythm"><div>Parastremmatic dysplasia</div></li><li class="half_rhythm"><div>Metatropic dysplasia</div></li></ul></li></ul><div id="cmt2c.Suggestive_Findings"><h3>Suggestive Findings</h3><div id="cmt2c.Neuromuscular_Disorders"><h4>Neuromuscular Disorders</h4><p>A <i>TRPV4</i>-associated neuromuscular disorder is suspected in individuals with the following range of clinical findings.</p><p><b>Charcot-Marie-Tooth disease type 2C (CMT2C)</b></p><ul><li class="half_rhythm"><div>A progressive peripheral neuronopathy/neuropathy (primarily motor, rather than sensory) associated with <i>pes cavus</i>, distal amyotrophy, and foot drop</div><ul><li class="half_rhythm"><div>Nerve conduction studies [<a class="bk_pop" href="#cmt2c.REF.dyck.1994.608">Dyck et al 1994</a>, <a class="bk_pop" href="#cmt2c.REF.zimo_.2010.1798">Zimo&#x00144; et al 2010</a>] show (a) reduced compound motor action potential (CMAP) amplitudes with normal velocities (&#x0003e;40-60 m/s), although occasionally they may be mildly abnormal (36-40 m/s); and (b) normal, decreased, or absent distal sensory nerve action potential (SNAP) amplitudes.</div></li><li class="half_rhythm"><div>Electromyography (EMG) shows predominantly chronic neurogenic changes.</div></li><li class="half_rhythm"><div>Nerve biopsy is infrequently employed as the findings (loss of myelinated fibers with signs of regeneration, axonal sprouting, and atrophic axons with neurofilaments) do not differentiate between various causes of axonal neuropathy.</div></li></ul></li><li class="half_rhythm"><div>Laryngeal dysfunction (i.e., vocal fold paresis) that may be bilateral and severe (resulting in inspiratory stridor and/or a raspy (hoarse) voice) or asymmetric (often more severe on the left than the right). Mild paresis may be inferred by presence of flaccid dysphonia [<a class="bk_pop" href="#cmt2c.REF.dyck.1994.608">Dyck et al 1994</a>]. Laryngoscopy often shows paresis of one or both vocal folds.</div></li><li class="half_rhythm"><div>Sensorineural hearing loss (SNHL), which is bilateral and progressive and ranges from mild to moderate. Onset is from childhood to adulthood [<a class="bk_pop" href="#cmt2c.REF.kannu.2007.2512">Kannu et al 2007</a>, <a class="bk_pop" href="#cmt2c.REF.landour_.2010.170">Landour&#x000e9; et al 2010</a>].</div></li><li class="half_rhythm"><div>Respiratory dysfunction in some cases including intercostal and diaphragm muscle weakness, which may lead to respiratory insufficiency and/or sleep apnea [<a class="bk_pop" href="#cmt2c.REF.chen.2010.1968">Chen et al 2010</a>]. Chest radiograph and pulmonary function tests may demonstrate diaphragm weakness with decreased inspiratory and expiratory pressures [<a class="bk_pop" href="#cmt2c.REF.dyck.1994.608">Dyck et al 1994</a>, <a class="bk_pop" href="#cmt2c.REF.donaghy.1999.552">Donaghy &#x00026; Kennett 1999</a>].</div></li><li class="half_rhythm"><div>Joint contractures (appearing similar to arthrogryposis multiplex congenita [AMC]) and short stature in some cases</div></li><li class="half_rhythm"><div>A family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance</div></li></ul><p><b>Scapuloperoneal spinal muscular atrophy (SPSMA)</b></p><ul><li class="half_rhythm"><div>Slowly progressive lower motor neuron loss associated with muscle weakness and atrophy proximally in the shoulder girdle region (with characteristic scapular winging) and distally in the peroneal (lower leg) muscles. In severe cases, absence of muscle and weakness are evident at birth [<a class="bk_pop" href="#cmt2c.REF.delong.1992.905">DeLong &#x00026; Siddique 1992</a>, <a class="bk_pop" href="#cmt2c.REF.auergrumbach.2010.160">Auer-Grumbach et al 2010</a>, <a class="bk_pop" href="#cmt2c.REF.deng.2010.165">Deng et al 2010</a>].</div></li><li class="half_rhythm"><div>Muscle biopsy (infrequently performed) showing evidence of denervation and renervation [<a class="bk_pop" href="#cmt2c.REF.deng.2010.165">Deng et al 2010</a>, <a class="bk_pop" href="#cmt2c.REF.berciano.2011.1413">Berciano et al 2011</a>]</div></li><li class="half_rhythm"><div>Laryngeal dysfunction (laryngomalacia and vocal fold anomalies as in <a href="#cmt2c.Neuromuscular_Disorders">CMT2C</a>), vocal cord paresis, and transient dysphonia [<a class="bk_pop" href="#cmt2c.REF.berciano.2011.1413">Berciano et al 2011</a>]</div></li><li class="half_rhythm"><div>SNHL (as in <a href="#cmt2c.Neuromuscular_Disorders">CMT2C</a>)</div></li><li class="half_rhythm"><div>Sensory deficits (rare)</div></li><li class="half_rhythm"><div>Kyphoscoliosis</div></li></ul><p><b>Congenital distal spinal muscular atrophy (CDSMA)</b></p><ul><li class="half_rhythm"><div>Congenital-onset, non-progressive or slowly progressive lower motor neuron loss associated with muscle weakness and atrophy, predominantly affecting the lower extremities (distal greater than proximal)</div></li><li class="half_rhythm"><div>Flexion contractures of the knees and hips often present at birth (i.e., arthrogryposis multiplex congenita [AMC])</div></li><li class="half_rhythm"><div>MRI of calf and thigh muscles showing a distinct pattern of fatty atrophy with preservation of the biceps femoris in the lateral thighs and of the medial gastrocnemius in the posteromedial calves [<a class="bk_pop" href="#cmt2c.REF.astrea.2012.364">Astrea et al 2012</a>]</div></li></ul><div id="cmt2c.T.neurologic_findings_by_trpv4asso" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Neurologic Findings by <i>TRPV4</i>-Associated Neuromuscular Phenotype</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK201366/table/cmt2c.T.neurologic_findings_by_trpv4asso/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2c.T.neurologic_findings_by_trpv4asso_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_1" style="text-align:left;vertical-align:middle;">Finding</th><th id="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th></tr><tr><th headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2" id="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">CMT2C</th><th headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2" id="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Scapuloperoneal SMA</th><th headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2" id="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital Distal SMA</th></tr></thead><tbody><tr><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Age at onset</b></td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Birth&#x02013;adulthood</td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Birth&#x02013;adulthood</td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Prenatal</td></tr><tr><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neuropathy</b></td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Peripheral, progressive (distal)</td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Peripheral, progressive (distal &#x0003e;proximal)</td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Paralysis of the legs at birth&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Vocal cord</b><br /><b>paralysis</b></td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+<br />(transient dysphonia)</td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x000b1;</td></tr><tr><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>SNHL</b></td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td></tr><tr><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b><br /><b>dysfunction&#x000a0;<sup>2</sup></b></td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td></tr><tr><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Joint</b><br /><b>contractures</b></td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AMC (involving feet, knee, hips)</td></tr><tr><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 3</td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 4</td><td headers="hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_1_2 hd_h_cmt2c.T.neurologic_findings_by_trpv4asso_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 5</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AMC = arthrogryposis multiplex <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>; CMT2C = Charcot-Marie-Tooth disease type 2C; SMA = spinal muscular atrophy; SNHL= sensorineural hearing loss</p></div></dd><dt>1. </dt><dd><div id="cmt2c.TF.1.1"><p class="no_margin">More mild manifestation: <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> weakness of the distal part of the lower limbs only. More severe manifestation: weakness of the pelvic girdle and trunk muscles, resulting in scoliosis.</p></div></dd><dt>2. </dt><dd><div id="cmt2c.TF.1.2"><p class="no_margin">Secondary to diaphragmatic and intercostal muscle involvement</p></div></dd><dt>3. </dt><dd><div id="cmt2c.TF.1.3"><p class="no_margin">Cold sensitivity (i.e., worsening of hand weakness in the cold)</p></div></dd><dt>4. </dt><dd><div id="cmt2c.TF.1.4"><p class="no_margin">Rounded shoulders, laterally displaced scapulae</p></div></dd><dt>5. </dt><dd><div id="cmt2c.TF.1.5"><p class="no_margin">Proximal muscle weakness (shoulder girdle, pelvic girdle) later in the disease course</p></div></dd></dl></div></div></div></div><div id="cmt2c.Skeletal_Dysplasias"><h4>Skeletal Dysplasias</h4><p>A <i>TRPV4</i>-associated skeletal dysplasia is suspected in individuals with the following skeletal findings:</p><ul><li class="half_rhythm"><div>Familial digital arthropathy-brachydactyly (FDAB) characterized by the following:</div><ul><li class="half_rhythm"><div>Normal hands and feet at birth, then relative shortening of the middle and distal phalanges with swelling and decreased range of motion of the interphalangeal joints in early childhood.</div></li><li class="half_rhythm"><div>Progressive arthropathy of the other joints of the hands and feet with pain and deformity.</div></li><li class="half_rhythm"><div>No clinical overlap with other <i>TRPV4-</i>associated skeletal dysplasias.</div></li></ul></li><li class="half_rhythm"><div>The other <i>TRPV4-</i>associated skeletal dysplasias (<a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> brachyolmia; spondylometaphyseal dysplasia, Kozlowski type; spondyloepiphyseal dysplasia, Maroteaux type; and parastremmatic dysplasia and metatropic dysplasia) form a phenotypic continuum of overlapping disorders from mild to severe, each with:</div><ul><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Progressive spinal deformity with scoliosis with or without kyphosis, and radiographic features of platyspondyly and overfaced pedicles</div></li><li class="half_rhythm"><div>At least one additional distinctive feature (see <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.radiographic_and_clinical_featur/?report=objectonly" target="object" rid-figpopup="figcmt2cTradiographicandclinicalfeatur" rid-ob="figobcmt2cTradiographicandclinicalfeatur">Table 2</a>)</div></li></ul></li></ul><div id="cmt2c.T.radiographic_and_clinical_featur" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Radiographic and Clinical Features of <i>TRPV4</i>-Associated Skeletal Dysplasias</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK201366/table/cmt2c.T.radiographic_and_clinical_featur/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2c.T.radiographic_and_clinical_featur_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_1" rowspan="3" scope="col" colspan="1" headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_1" style="text-align:left;vertical-align:middle;">Feature</th><th id="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2" colspan="6" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th></tr><tr><th headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2" id="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Mild</th><th headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2" id="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Intermediate</th><th headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2" id="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Severe</th></tr><tr><th headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_1" id="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Familial digital arthropathy-brachydactyly</th><th headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2" id="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Autosomal dominant brachyolmia</th><th headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2" id="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spondylo-metaphyseal dysplasia, Kozlowski type</th><th headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2" id="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spondylo-epiphyseal dysplasia, Maroteaux type</th><th headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_3" id="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Parastremmatic dysplasia&#x000a0;<sup>1</sup></th><th headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_3" id="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Metatropic dysplasia</th></tr></thead><tbody><tr><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hands/</b><br /><b>feet</b></td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_1 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal at birth; progressive swelling &#x00026; arthropathy (see <a href="#cmt2c.Skeletal_Dysplasias">details</a>)</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinodactyly</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Brachydactyly; hypoplastic carpal bones w/severe delay in ossification</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Brachydactyly</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_3 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Joint contractures</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_3 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Brachydactyly w/delayed carpal ossification</td></tr><tr><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Spine</b></td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_1 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x000b1; Scoliosis, kyphosis; mild platyspondyly</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_3 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_4" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">Platyspondyly; overfaced pedicles&#x000a0;<sup>2</sup></td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_3 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Significant kyphoscoliosis; overfaced pedicles&#x000a0;<sup>2</sup></td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_3 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Platyspondyly; overfaced pedicles&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Long bones</b></td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_1 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Minimal metaphyseal changes; short femoral neck w/irregular proximal femoral metaphyses</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x000b1; Mild metaphyseal changes; genu varum</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild to moderate metaphyseal changes; genu varum</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_3 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe metaphyseal changes w/severe limb deformity; joint contractures; other&#x000a0;<sup>3</sup></td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_3 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dumbbell-shaped long bones w/epiphyseal dysplasia &#x00026; prominent joints; progressive joint contractures; other&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pelvis</b></td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_1 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Square, short, flared iliac wings; flat, irregular acetabulae; coxa vara; &#x000b1; supra-acetabular notches</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Champagne-glass configuration of pelvic inlet</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_3 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_5 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_6" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">Halberd-shaped&#x000a0;<sup>5</sup> pelvis; supra-acetabular notches</td></tr><tr><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_1 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Average height; early-childhood onset</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild short stature; limbs unaffected; good physical function</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Short-trunk short-stature dwarfism; broad chest; early-childhood onset w/waddling gait</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Short-trunk short-stature dwarfism</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_3 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Significant short-trunk short-stature dwarfism</td><td headers="hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_1_2 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_2_3 hd_h_cmt2c.T.radiographic_and_clinical_featur_1_1_3_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May be lethal prenatally or perinatally; at birth, short-limb short-stature dwarfism&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cmt2c.TF.2.1"><p class="no_margin">Rarest <i>TRPV4</i>-related skeletal dysplasia</p></div></dd><dt>2. </dt><dd><div id="cmt2c.TF.2.2"><p class="no_margin">Overfaced pedicles = lateral border of the vertebrae appears outside the lateral edge of the pedicles, a characteristic feature of <i>TRPV4</i>-associated skeletal dysplasias best viewed on AP x-ray of the spine; images in <a class="bk_pop" href="#cmt2c.REF.nemec.2012.15">Nemec et al [2012]</a>.</p></div></dd><dt>3. </dt><dd><div id="cmt2c.TF.2.3"><p class="no_margin">Additional findings: hyperplastic femoral trochanters; severe genu valgum; bowing of long bones; legs twisted along the long axis</p></div></dd><dt>4. </dt><dd><div id="cmt2c.TF.2.4"><p class="no_margin">Histologic findings: thin seal of bone at the chondroosseous junction; absent primary metaphyseal spongiosa; abnormal metaphyseal vascular invasion; arrest of endochondral ring structures with persistence of circumferential growth</p></div></dd><dt>5. </dt><dd><div id="cmt2c.TF.2.5"><p class="no_margin">Halberd-shaped pelvis is derived from the shape of a Swedish battle ax.</p></div></dd><dt>6. </dt><dd><div id="cmt2c.TF.2.6"><p class="no_margin">Progressive kyphoscoliosis and platyspondyly subsequently alter proportions from short-limb to short-trunk dwarfism.</p></div></dd></dl></div></div></div></div></div><div id="cmt2c.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of a <i>TRPV4</i>-associated disorder is established in an individual with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>TRPV4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>One genetic testing strategy</b> is <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>TRPV4</i> (<a class="figpopup" href="/books/NBK201366/table/cmt2c.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figcmt2cTmoleculargenetictestingusedi" rid-ob="figobcmt2cTmoleculargenetictestingusedi">Table 3</a>).</p><p><b>Another genetic testing strategy</b> is use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>TRPV4</i> and other genes of interest (see <a href="#cmt2c.Differential_Diagnosis">Differential Diagnosis</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><div id="cmt2c.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>TRPV4</i>-Associated Neuromuscular and Skeletal Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK201366/table/cmt2c.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2c.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cmt2c.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_cmt2c.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_cmt2c.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_cmt2c.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>TRPV4</i></td><td headers="hd_h_cmt2c.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_cmt2c.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%</td></tr><tr><td headers="hd_h_cmt2c.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_cmt2c.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 4</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cmt2c.TF.3.1"><p class="no_margin">See <a href="/books/NBK201366/#cmt2c.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#cmt2c.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="cmt2c.TF.3.2"><p class="no_margin">Sequence analysis can detect variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="cmt2c.TF.3.3"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>4. </dt><dd><div id="cmt2c.TF.3.4"><p class="no_margin">The authors are unaware of a whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> of <i>TRPV4</i> causing one of the recognized phenotypes.</p></div></dd></dl></div></div></div></div></div><div id="cmt2c.Clinical_Characteristics"><h2 id="_cmt2c_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cmt2c.Clinical_Description"><h3>Clinical Description</h3><p>The two groups of disorders and the phenotypes comprising <i>TRPV4</i>-associated disorders (listed from mildest to most severe) are:</p><ul><li class="half_rhythm"><div>Neuromuscular disorders (see <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.neurologic_findings_by_trpv4asso/?report=objectonly" target="object" rid-figpopup="figcmt2cTneurologicfindingsbytrpv4asso" rid-ob="figobcmt2cTneurologicfindingsbytrpv4asso">Table 1</a>):</div><ul><li class="half_rhythm"><div>Charcot-Marie-Tooth disease type 2C</div></li><li class="half_rhythm"><div>Scapuloperoneal spinal muscular atrophy</div></li><li class="half_rhythm"><div>Congenital distal spinal muscular atrophy</div></li></ul></li><li class="half_rhythm"><div>Skeletal dysplasias (see <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.radiographic_and_clinical_featur/?report=objectonly" target="object" rid-figpopup="figcmt2cTradiographicandclinicalfeatur" rid-ob="figobcmt2cTradiographicandclinicalfeatur">Table 2</a>):</div><ul><li class="half_rhythm"><div>Familial digital arthropathy-brachydactyly</div></li><li class="half_rhythm"><div>Autosomal dominant brachyolmia</div></li><li class="half_rhythm"><div>Spondylometaphyseal dysplasia, Kozlowski type</div></li><li class="half_rhythm"><div>Spondyloepiphyseal dysplasia, Maroteaux type</div></li><li class="half_rhythm"><div>Parastremmatic dysplasia</div></li><li class="half_rhythm"><div>Metatropic dysplasia</div></li></ul></li></ul><p>The phenotypic spectra within both groups are broad and overlapping, and the phenotypes of both groups often overlap as well [<a class="bk_pop" href="#cmt2c.REF.chen.2010.1968">Chen et al 2010</a>, <a class="bk_pop" href="#cmt2c.REF.unger.2011.2860">Unger et al 2011</a>, <a class="bk_pop" href="#cmt2c.REF.cho.2012.795">Cho et al 2012</a>].</p><p>Of note, sensorineural hearing loss (SNHL), which is bilateral and progressive and ranges from mild to moderate, can occur in both phenotypes. Onset is from childhood to adulthood [<a class="bk_pop" href="#cmt2c.REF.kannu.2007.2512">Kannu et al 2007</a>, <a class="bk_pop" href="#cmt2c.REF.landour_.2010.170">Landour&#x000e9; et al 2010</a>].</p><div id="cmt2c.Neuromuscular_Disorders_1"><h4>Neuromuscular Disorders</h4><p>The <i>TRPV4</i>-associated neuromuscular disorders are peripheral neuropathies/neuronopathies in which motor nerves are more prominently affected than sensory nerves [<a class="bk_pop" href="#cmt2c.REF.delong.1992.905">DeLong &#x00026; Siddique 1992</a>, <a class="bk_pop" href="#cmt2c.REF.dyck.1994.608">Dyck et al 1994</a>, <a class="bk_pop" href="#cmt2c.REF.landour_.2010.170">Landour&#x000e9; et al 2010</a>].</p><p>Clinical findings and age of onset can be extremely variable in <i>TRPV4</i>-associated neuromuscular disorders both between and within families [<a class="bk_pop" href="#cmt2c.REF.dyck.1994.608">Dyck et al 1994</a>, <a class="bk_pop" href="#cmt2c.REF.donaghy.1999.552">Donaghy &#x00026; Kennett 1999</a>, <a class="bk_pop" href="#cmt2c.REF.zimo_.2010.1798">Zimo&#x00144; et al 2010</a>]. In some, the disease can be so mild as to go unrecognized by the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual and his/her physicians.</p><p>Affected individuals usually become symptomatic between early childhood and age 25 years; however, disease onset can range from birth with breathing difficulties and delayed walking to after the eighth decade [<a class="bk_pop" href="#cmt2c.REF.dyck.1994.608">Dyck et al 1994</a>].</p><p>Affected individuals typically have progressive weakness and atrophy of distal muscles in the feet and/or hands, usually associated with depressed tendon reflexes and mild or no sensory loss. Mild sensory deficits of position, vibration, and pain/temperature may occur in the feet or sensation may be intact.</p><p>Laryngeal dysfunction is a hallmark of Charcot-Marie-Tooth disease type 2C (CMT2C) and often observed in individuals with scapuloperoneal spinal muscular atrophy (SPSMA) and those with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> distal spinal muscular atrophy (CDSMA) [<a class="bk_pop" href="#cmt2c.REF.dyck.1994.608">Dyck et al 1994</a>, <a class="bk_pop" href="#cmt2c.REF.auergrumbach.2010.160">Auer-Grumbach et al 2010</a>, <a class="bk_pop" href="#cmt2c.REF.deng.2010.165">Deng et al 2010</a>, <a class="bk_pop" href="#cmt2c.REF.landour_.2010.170">Landour&#x000e9; et al 2010</a>, <a class="bk_pop" href="#cmt2c.REF.zimo_.2010.1798">Zimo&#x00144; et al 2010</a>].</p><p>The typical presenting symptoms are difficulty with phonation and breathing (inspiratory stridor) and distal leg weakness and atrophy.</p><p>Individuals with <i>TRPV4</i>-associated neuromuscular disorders typically have bilateral foot drop, symmetric atrophy of the muscles below the knee (stork leg appearance), and absent tendon reflexes in the legs. Atrophy of the intrinsic hand muscles is common; tendon reflexes may be intact in the arms.</p><p>Proximal limb muscles may be involved in severe cases, particularly in scapuloperoneal spinal muscular atrophy (SPSMA). As the name suggests, the pattern of muscle involvement includes progressive shoulder girdle atrophy and weakness leading to scapular winging (scapula alata) and involvement of the two muscle groups below the knee (peroneal distribution) [<a class="bk_pop" href="#cmt2c.REF.delong.1992.905">DeLong &#x00026; Siddique 1992</a>].</p><p><i>TRPV4</i>-associated neuromuscular disorders are progressive over many years. However, for the <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> forms &#x02013; SPSMA and CDSMA &#x02013; <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals experience long plateau periods without obvious deterioration [<a class="bk_pop" href="#cmt2c.REF.delong.1992.905">DeLong &#x00026; Siddique 1992</a>, <a class="bk_pop" href="#cmt2c.REF.vlam.2012.790">Vlam et al 2012</a>].</p><p>The disease may decrease life span in severe cases, secondary to respiratory complications [<a class="bk_pop" href="#cmt2c.REF.dyck.1994.608">Dyck et al 1994</a>, <a class="bk_pop" href="#cmt2c.REF.donaghy.1999.552">Donaghy &#x00026; Kennett 1999</a>, <a class="bk_pop" href="#cmt2c.REF.santoro.2002.399">Santoro et al 2002</a>, <a class="bk_pop" href="#cmt2c.REF.mcentagart.2005.293">McEntagart et al 2005</a>].</p></div><div id="cmt2c.Skeletal_Dysplasias_1"><h4>Skeletal Dysplasias</h4><p><b>Familial digital arthropathy-brachydactyly</b> is not evident at birth because the hands and feet and skeletal examination (including radiographs) are normal. In early childhood relative shortening of the middle and distal phalanges and swelling and decreased range of motion of the interphalangeal joints become apparent. Later in the first decade and beyond, the other joints of the hands and feet become painful and deformed. No overlap is currently recognized with the manifestations of the other <i>TRPV4-</i>associated skeletal dysplasias.</p><p>The remaining <i>TRPV4-</i>associated skeletal disorders are characterized by varying degrees of disproportionate short stature and progressive spinal deformity with scoliosis with or without kyphosis.</p><p><b>Autosomal dominant brachyolmia</b> is the mildest of the short stature <i>TRPV4</i> skeletal conditions. Its name was derived from the Greek roots <i>brachy-</i>, meaning "short," and -<i>olmos</i>, meaning "trunk" or "shoulder." Affected individuals have only mild short stature and the limbs are typically unaffected; thus, physical function is unaffected.</p><p><b>Spondylometaphyseal dysplasia, Kozlowski type</b> is marked by short-trunk short stature, although the chest is broader than in some of the more severe <i>TRPV4</i>-associated skeletal dysplasias. Birth length is average. Affected children usually come to medical attention in early childhood when poor growth with disproportionate stature and a waddling gait with genu varum become evident. Premature osteoarthritis of the joints is common.</p><p><b>Spondyloepiphyseal dysplasia, Maroteaux type</b> is marked by short-trunk dwarfism and brachydactyly. Birth length is usually average. Poor growth with a short trunk and overall short stature become evident in childhood. Over time, genu valgum and kyphoscoliosis develop. Osteoporosis has been described.</p><p><b>Parastremmatic dysplasia,</b> probably the rarest of the <i>TRPV4</i>-associated skeletal dysplasias, is characterized by severe limb deformities and joint malalignment, short stature, and kyphoscoliosis, which are present at birth and progressively worsen throughout life.</p><p><b>Metatropic dysplasia</b> (from Greek <i>metatropos,</i> meaning "with change/changing pattern") was named after the striking reversal of body proportions between birth and childhood. At birth, the limbs are disproportionately short (due the long bone metaphyseal abnormalities) compared to the trunk. In childhood when the platyspondyly and scoliosis and/or kyphosis become more severe, the trunk becomes relatively short compared to the limbs.</p><p>Metatropic dysplasia may be lethal in the prenatal or perinatal period, largely due to an extremely narrow chest and hypoplastic lung parenchyma. Infants who survive the perinatal period typically develop severe kyphoscoliosis that eventually compromises pulmonary function. Other skeletal findings in some individuals with severe metatropic dysplasia are poor joint range of motion, joint contractures, and torticollis; these arthrogryposis multiplex congenita-like contractures represent an overlap between the neuromuscular and skeletal phenotypes of <i>TRPV4</i>-associated disorders [<a class="bk_pop" href="#cmt2c.REF.unger.2011.2860">Unger et al 2011</a>].</p></div></div><div id="cmt2c.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>In general, specific sets of <i>TRPV4</i> pathogenic variants have been associated with either neuromuscular disorders or skeletal dysplasia; overlap may occur, however, making <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> difficult [<a class="bk_pop" href="#cmt2c.REF.unger.2011.2860">Unger et al 2011</a>, <a class="bk_pop" href="#cmt2c.REF.sullivan.2013.c999">Sullivan &#x00026; Earley 2013</a>]. See also <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.selected_trpv4_variants/?report=objectonly" target="object" rid-figpopup="figcmt2cTselectedtrpv4variants" rid-ob="figobcmt2cTselectedtrpv4variants">Table 4</a>.</p><p>Of note, the pathogenic variants <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.selected_trpv4_variants/?report=objectonly" target="object" rid-figpopup="figcmt2cTselectedtrpv4variants" rid-ob="figobcmt2cTselectedtrpv4variants">p.Tyr591Cys</a>, <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.selected_trpv4_variants/?report=objectonly" target="object" rid-figpopup="figcmt2cTselectedtrpv4variants" rid-ob="figobcmt2cTselectedtrpv4variants">p.Arg594His</a>, <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.selected_trpv4_variants/?report=objectonly" target="object" rid-figpopup="figcmt2cTselectedtrpv4variants" rid-ob="figobcmt2cTselectedtrpv4variants">p.Glu797Lys</a>, and <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.selected_trpv4_variants/?report=objectonly" target="object" rid-figpopup="figcmt2cTselectedtrpv4variants" rid-ob="figobcmt2cTselectedtrpv4variants">p.Pro799Leu</a> have been associated with both neuromuscular disease and skeletal dysplasia. In addition, the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.selected_trpv4_variants/?report=objectonly" target="object" rid-figpopup="figcmt2cTselectedtrpv4variants" rid-ob="figobcmt2cTselectedtrpv4variants">p.Ser542Tyr</a> caused both CMT2C and short stature in one family [<a class="bk_pop" href="#cmt2c.REF.chen.2010.1968">Chen et al 2010</a>].</p><p>Functional studies suggest that <i>TRPV4</i> pathogenic variants associated with neuromuscular disorders and skeletal dysplasias may cause a gain of channel function [<a class="bk_pop" href="#cmt2c.REF.rock.2008.999">Rock et al 2008</a>, <a class="bk_pop" href="#cmt2c.REF.krakow.2009.307">Krakow et al 2009</a>, <a class="bk_pop" href="#cmt2c.REF.nilius.2013.152">Nilius &#x00026; Voets 2013</a>], whereas the pathogenic variants associated with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> digital arthropathy-brachydactyly (FDAB) may cause a loss of channel function.</p><p><b><i>TRPV4</i>-associated neuromuscular disorders.</b> Several studies suggest that most <i>TRPV4</i> pathogenic variants associated with a neuromuscular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> cluster on the highly positively charged convex surface of the ankyrin repeats <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and target arginine residues that are strictly conserved throughout 27 available <i>TRPV4</i> orthologs [<a class="bk_pop" href="#cmt2c.REF.auergrumbach.2010.160">Auer-Grumbach et al 2010</a>, <a class="bk_pop" href="#cmt2c.REF.deng.2010.165">Deng et al 2010</a>, <a class="bk_pop" href="#cmt2c.REF.landour_.2010.170">Landour&#x000e9; et al 2010</a>]. These surface pathogenic variants are located in three consecutive finger loops of the protein, a distinct region of the <i>TRPV4</i> ankyrin repeats.</p><ul><li class="half_rhythm"><div>At least 13 <i>TRPV4</i> pathogenic variants cause CMT2C and are predominantly in the N-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, but others are located in different protein regions.</div></li><li class="half_rhythm"><div>The eight <i>TRPV4</i> pathogenic variants that cause SPSMA are located in either the N-terminus or the transmembrane region [<a class="bk_pop" href="#cmt2c.REF.nilius.2013.152">Nilius &#x00026; Voets 2013</a>].</div></li><li class="half_rhythm"><div>The six different <i>TRPV4</i> pathogenic variants that cause <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> distal spinal muscular atrophy are located in the N-terminal cytosolic tail of the <i>TRPV4</i> proteins [<a class="bk_pop" href="#cmt2c.REF.fiorillo.2012.195">Fiorillo et al 2012</a>].</div></li></ul><p><b><i>TRPV4-</i>associated skeletal dysplasias.</b> The <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> digital arthropathy-brachydactyly (FDAB)-causing pathogenic variants are restricted to finger 3 of the ankyrin repeats <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (ARD: pathogenic variants <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.selected_trpv4_variants/?report=objectonly" target="object" rid-figpopup="figcmt2cTselectedtrpv4variants" rid-ob="figobcmt2cTselectedtrpv4variants">p.Gly270Val</a>, <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.selected_trpv4_variants/?report=objectonly" target="object" rid-figpopup="figcmt2cTselectedtrpv4variants" rid-ob="figobcmt2cTselectedtrpv4variants">p.Arg271Pro</a>, <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.selected_trpv4_variants/?report=objectonly" target="object" rid-figpopup="figcmt2cTselectedtrpv4variants" rid-ob="figobcmt2cTselectedtrpv4variants">p.Phe273Leu</a>) [<a class="bk_pop" href="#cmt2c.REF.nilius.2013.152">Nilius &#x00026; Voets 2013</a>].</p><p>In total, more than 50 pathogenic variants in <i>TRPV4</i> have been reported to cause brachyolmias. While the pathogenic variants are spread throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, two hot spots have been observed at residues Pro799 in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 15 and Arg594 in exon 11 [<a class="bk_pop" href="#cmt2c.REF.nishimura.2012.190">Nishimura et al 2012</a>], which localize to the channel pore region.</p></div><div id="cmt2c.Penetrance"><h3>Penetrance</h3><p><b><i>TRPV4</i>-associated neuromuscular disorders.</b> Penetrance is incomplete with the neuromuscular disease-associated pathogenic variants. Non-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> has been described for the <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.selected_trpv4_variants/?report=objectonly" target="object" rid-figpopup="figcmt2cTselectedtrpv4variants" rid-ob="figobcmt2cTselectedtrpv4variants">p.Arg232Cys</a> and <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.selected_trpv4_variants/?report=objectonly" target="object" rid-figpopup="figcmt2cTselectedtrpv4variants" rid-ob="figobcmt2cTselectedtrpv4variants">p.Arg315Trp</a> variants.</p><p>No difference in <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is observed between males and females.</p><p>Incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is known in the hereditary peripheral neuropathies, and for example has been observed for pathogenic variants in <a href="/books/n/gene/cmt2d/"><i>GARS1</i></a>, encoding glycyltRNA synthetase (see <a href="/books/n/gene/cmt2d/"><i>GARS1</i>-Associated Neuropathies</a>) [<a class="bk_pop" href="#cmt2c.REF.sivakumar.2005.2304">Sivakumar et al 2005</a>]; <i>MPZ</i>, encoding myelin protein zero (see <a href="/books/n/gene/cmt/">CMT</a> Overview) [<a class="bk_pop" href="#cmt2c.REF.de_jonghe.1999.281">De Jonghe et al 1999</a>]; and <i>BSCL2</i>, encoding seipin (see <a href="/books/n/gene/bscl/">Berardinelli-Seip Congenital Lipodystrophy</a> and <a href="/books/n/gene/spg17/"><i>BSCL2</i>-Related Neurologic Disorders/Seipinopathy</a>) [<a class="bk_pop" href="#cmt2c.REF.auergrumbach.2005.415">Auer-Grumbach et al 2005</a>]. In <i>TRPV4</i>-associated neuropathy, however, reduced penetrance appears to be a relatively common feature that is not variant specific [<a class="bk_pop" href="#cmt2c.REF.zimo_.2010.1798">Zimo&#x00144; et al 2010</a>].</p><p><b><i>TRPV4</i>-associated skeletal dysplasias.</b> In contrast, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the skeletal dysplasia <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> appears to be high; however, intra- and <a class="def" href="/books/n/gene/glossary/def-item/interfamilial-variability/">interfamilial variability</a> is significant [<a class="bk_pop" href="#cmt2c.REF.dai.2010.704">Dai et al 2010</a>].</p></div><div id="cmt2c.Nomenclature"><h3>Nomenclature</h3><p>Charcot-Marie-Tooth neuropathy type 2C is also referred to as hereditary motor and sensory neuropathy type 2C.</p><p>Spondyloepiphyseal dysplasia, Maroteaux type is also referred to as pseudo-Morquio syndrome type 2.</p></div><div id="cmt2c.Prevalence"><h3>Prevalence</h3><p>The prevalence of the <i>TRPV4</i>-associated neuromuscular and skeletal dysplasias has not been well studied.</p><p><a class="bk_pop" href="#cmt2c.REF.fawcett.2012.1204">Fawcett et al [2012]</a> determined that 13 (&#x0003c;1%) of 422 individuals with a CMT2 (axonal CMT) <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> were <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>TRPV4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Of note, the detection of a <i>TRPV4</i> pathogenic variant increased to 9% in those with an unusual CMT2 presentation (e.g., vocal fold and diaphragmatic paresis).</p></div></div><div id="cmt2c.Genetically_Related_Allelic_Disord"><h2 id="_cmt2c_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those described in this <i>GeneReview</i> have been associated with pathogenic variants in <i>TRPV4.</i></p></div><div id="cmt2c.Differential_Diagnosis"><h2 id="_cmt2c_Differential_Diagnosis_">Differential Diagnosis</h2><p><b><i>TRPV4</i>-associated neuromuscular disorders</b> (Charcot-Marie-Tooth disease type 2C [CMT2C], scapuloperoneal spinal muscular atrophy, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> distal spinal muscular atrophy) resemble several other disorders (see note):</p><ul><li class="half_rhythm"><div>A similar, but pure motor syndrome without sensory loss, termed "distal hereditary motor neuropathy VII" (dHMV-VII) and linked to <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 2q12.3, caused by pathogenic variants in <i>SLC5A7</i> [<a class="bk_pop" href="#cmt2c.REF.mcentagart.2001.1270">McEntagart et al 2001</a>, <a class="bk_pop" href="#cmt2c.REF.barwick.2012.1103">Barwick et al 2012</a>]</div></li><li class="half_rhythm"><div>Autosomal dominant motor neuropathy with vocal paralysis associated with a <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>DCTN1,</i> encoding the protein dynactin 1 [<a class="bk_pop" href="#cmt2c.REF.puls.2003.455">Puls et al 2003</a>]</div></li><li class="half_rhythm"><div>Other <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> distal spinal muscular atrophies caused by pathogenic variants in the following genes: <i>HSPB1</i>, <i>HSPB3</i>, <i>HSPB8</i>, <i>GARS1</i>, <a href="/books/n/gene/spg17/"><i>BSCL2</i></a>, <i>IGHMBP2</i>, <a href="/books/n/gene/perry/"><i>DCTN1</i></a>, <i>ATP7A</i>, <i>SETX</i>, <i>DYNC1H1</i>, and <i>PLEKHG5</i> [<a class="bk_pop" href="#cmt2c.REF.rossor.2012.6">Rossor et al 2012</a>]</div></li><li class="half_rhythm"><div>Autosomal dominant <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> spinal muscular atrophy caused by pathogenic variants in <i>BICD2</i> [reported by <a class="bk_pop" href="#cmt2c.REF.oates.2012.1714">Oates et al 2012</a>]</div></li></ul><p>Note: See <a href="/books/n/gene/cmt/">Charcot-Marie-Tooth Neuropathy</a> for a general overview of CMT2.</p><p><b><i>TRPV4</i>-associated skeletal dysplasias</b> have a broad phenotypic spectrum and, thus, many skeletal dysplasias to consider in the differential diagnosis.</p><p><b>Mild</b> (<a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> digital arthropathy-brachydactyly). The differential diagnosis includes reactive arthropathy, diabetic arthropathy, and other forms of brachydactyly [<a class="bk_pop" href="#cmt2c.REF.amor.2002.235">Amor et al 2002</a>].</p><p><b>Intermediate</b> (<a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> brachyolmia; spondylometaphyseal dysplasia, Kozlowski type; and spondyloepiphyseal dysplasia, Maroteaux type). The differential diagnosis includes the following [<a class="bk_pop" href="#cmt2c.REF.krakow.2009.307">Krakow et al 2009</a>, <a class="bk_pop" href="#cmt2c.REF.dai.2010.704">Dai et al 2010</a>]:</p><ul><li class="half_rhythm"><div>Brachyolmia types 1 and 2</div></li><li class="half_rhythm"><div><a href="/books/n/gene/sedt/">X-linked spondyloepiphyseal dysplasia tarda</a> (<a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> SEDT) caused by pathogenic variants in <i>TRAPPC2</i></div></li><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders:</div><ul><li class="half_rhythm"><div>Spondyloepiphyseal dysplasia congenita SED caused by pathogenic variants in <i>COL2A1</i></div></li><li class="half_rhythm"><div><a href="/books/n/gene/mps4a/">Morquio syndrome type A</a> caused by pathogenic variants in <i>GALNS</i></div></li><li class="half_rhythm"><div><a href="/books/n/gene/gm1-ganglio/">Morquio syndrome type B</a> caused by pathogenic variants in <i>GLB1</i></div></li></ul></li></ul><p><b>Severe</b> (parastremmatic dysplasia and metatropic dysplasia). The differential diagnosis includes the following [<a class="bk_pop" href="#cmt2c.REF.maroteaux.1966.211">Maroteaux et al 1966</a>, <a class="bk_pop" href="#cmt2c.REF.beck.1983.231">Beck et al 1983</a>, <a class="bk_pop" href="#cmt2c.REF.hall.2004.66">Hall &#x00026; Elcioglu 2004</a>]:</p><ul><li class="half_rhythm"><div>Weissenbacher Zweymuller syndrome</div></li><li class="half_rhythm"><div>Fibrochondrogenesis (rhizomelic limb shortening, broad dumbbell-shaped metaphyses, pear-shaped vertebral bodies, short and distally cupped ribs)</div></li><li class="half_rhythm"><div>Kniest syndrome (platyspondyly and coronal cleft, shortened tubular bones and metaphyseal flaring, broad and short thorax)</div></li><li class="half_rhythm"><div>Dyssegmental dysplasia</div></li></ul></div><div id="cmt2c.Management"><h2 id="_cmt2c_Management_">Management</h2><div id="cmt2c.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with a <b><i>TRPV4</i>-associated neuromuscular disorder</b>, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Physical/neurologic examination to determine extent of weakness and atrophy, <i>pes cavus</i>, gait stability, and sensory loss</div></li><li class="half_rhythm"><div>Electromyography (EMG) with nerve conduction velocity (NCV)</div></li><li class="half_rhythm"><div>ENT consultation with laryngoscopy, as needed to document the status of the vocal folds</div></li><li class="half_rhythm"><div>Pulmonary function testing and dynamic breathing chest x-ray</div></li><li class="half_rhythm"><div>Hearing assessment (See <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a> for different types of hearing assessment.)</div></li><li class="half_rhythm"><div>Skeletal x-rays to document any associated skeletal dysplasia</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul><p>To establish the extent of disease and needs in an individual diagnosed with a <b><i>TRPV4</i>-associated skeletal dysplasia</b>, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Skeletal radiographs to document involvement of the long bones and spine, which can help determine patient needs as well as provide a baseline for comparison with future studies</div></li><li class="half_rhythm"><div>Flexion/extension cervical spine films to determine if there is atlanto-axial instability secondary to odontoid hypoplasia</div></li><li class="half_rhythm"><div>Pulmonary function tests and/or sleep study if the thorax is particularly narrow and/or kyphoscoliosis is progressive</div></li><li class="half_rhythm"><div>Hearing assessment (See <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a> for different types of hearing assessment.)</div></li></ul></div><div id="cmt2c.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment is symptomatic. Affected individuals are often evaluated and managed by a multidisciplinary team that includes neurologists, physiatrists, orthopedic surgeons, and physical and occupational therapists [<a class="bk_pop" href="#cmt2c.REF.grandis.2005.23">Grandis &#x00026; Shy 2005</a>].</p><p>For treatment of findings common to <b>all</b>
<b><i>TRPV4</i>-associated disorders</b></p><ul><li class="half_rhythm"><div>Sensorineural hearing loss. Referral to hearing loss specialists to determine the extent of hearing loss and the best habilitation options for sensorineural hearing loss (See <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a> for discussion of management issues.)</div></li><li class="half_rhythm"><div>Pain and depression. Symptomatic treatment</div></li></ul><p>For the <i>TRPV4</i>-associated <b>neuromuscular disorders</b> the following are indicated:</p><ul><li class="half_rhythm"><div><b>Neuropathy</b></div><ul><li class="half_rhythm"><div>Special shoes, including those with good ankle support</div></li><li class="half_rhythm"><div>Ankle/foot orthoses (AFO) to correct foot drop and aid walking</div></li><li class="half_rhythm"><div>Orthopedic surgery to correct severe <i>pes cavus</i> deformity as needed [<a class="bk_pop" href="#cmt2c.REF.guyton.2000.317">Guyton &#x00026; Mann 2000</a>]</div></li><li class="half_rhythm"><div>Forearm crutches, canes/walkers for gait stability, and wheelchairs</div></li><li class="half_rhythm"><div>Exercise within the individual's capability (Many individuals remain physically active.)</div></li><li class="half_rhythm"><div>Symptomatic treatment of pain and depression [<a class="bk_pop" href="#cmt2c.REF.gemignani.2004.7">Gemignani et al 2004</a>, <a class="bk_pop" href="#cmt2c.REF.padua.2006.417">Padua et al 2006</a>]</div></li></ul></li><li class="half_rhythm"><div><b>Vocal cord involvement</b></div><ul><li class="half_rhythm"><div>Laryngeal surgery for vocal fold paresis (arytenoidectomy and tracheostomy)</div></li><li class="half_rhythm"><div>Speech therapy</div></li></ul></li><li class="half_rhythm"><div><b>Respiratory dysfunction.</b> Respiratory therapy/support (e.g., BiPAP)</div></li></ul><p>For the <i>TRPV4</i>-associated <b>skeletal dysplasias</b> the following treatments may be indicated:</p><ul><li class="half_rhythm"><div>Physical therapy/exercise to maintain as much function as possible. Daily heel cord-stretching exercises are helpful in preventing Achilles' tendon shortening.</div></li><li class="half_rhythm"><div>Orthopedic evaluation with consideration of surgical intervention (i.e., spinal fusion) when kyphoscoliosis compromises pulmonary function and/or causes pain</div></li><li class="half_rhythm"><div>Odontoid hypoplasia. When upper cervical spine instability is documented or when clinical findings of cervical myelopathy are present, occipito-cervical or upper cervical decompression and fusion are required to stabilize the upper cervical spine and relieve cervical cord compression. To minimize neurologic injury and maximize function, it is preferred that intervention in children occur when radiographic signs of cervical compression are present, even in the absence of symptoms. Patients undergoing surgical fusion typically do well; minor secondary complications can include pin site infections, pressure sores, and long-term difficulty with endotracheal intubation. Note: It is important for clinicians to be aware that cervical myelopathy from upper cervical instability may result in deteriorating endurance and worsening gait. If myelopathy is suspected, obtain cervical spine radiographs and MRI. The patient should be referred for evaluation by a pediatric orthopedic surgeon or neurosurgeon at a tertiary care facility.</div></li><li class="half_rhythm"><div>Symptomatic treatment of pain and depression (which can influence physical function). Note that chronic pain management preceding or following orthopedic surgery is standard and often required.</div></li></ul></div><div id="cmt2c.Surveillance"><h3>Surveillance</h3><p><b><i>TRPV4</i>-associated neuromuscular disorders.</b> Annual:</p><ul><li class="half_rhythm"><div>Neurologic examination to determine extent of weakness and atrophy, and sensory loss</div></li><li class="half_rhythm"><div>Physical therapy examination to monitor feet to determine need for bracing, special shoes, and/or surgery</div></li><li class="half_rhythm"><div>ENT consultation with laryngoscopy</div></li><li class="half_rhythm"><div>Dynamic breathing chest x-ray</div></li><li class="half_rhythm"><div>Hearing assessment</div></li></ul><p><b><i>TRPV4</i>-associated skeletal dysplasias</b></p><ul><li class="half_rhythm"><div>Annual assessment for the development of joint pain and scoliosis</div></li><li class="half_rhythm"><div>Cervical spinal films to assess for clinically significant odontoid hypoplasia before:</div><ul><li class="half_rhythm"><div>A child reaches school age;</div></li><li class="half_rhythm"><div>Surgical procedures involving general anesthesia.</div></li></ul></li></ul></div><div id="cmt2c.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>No specific data are available for <i>TRPV4</i>-associated neuromuscular or skeletal disorders.</p><p>In general, obesity is to be avoided because it makes walking more difficult for individuals with neuropathy, skeletal dysplasia, or both.</p><p><b>For neuromuscular disorders.</b> Medications that are toxic or potentially toxic to persons with CMT comprise a spectrum of risk ranging from definite high risk to negligible risk. See the Charcot-Marie-Tooth Association <a href="https://www.cmtausa.org/living-with-cmt/managing-cmt/medications/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">website</a> (pdf) for an up-to-date list.</p><p><b>For skeletal dysplasias</b></p><ul><li class="half_rhythm"><div>In individuals with odontoid hypoplasia, extreme neck flexion and extension</div></li><li class="half_rhythm"><div>Activities and occupations that place undue stress on the spine and weight-bearing joints</div></li></ul></div><div id="cmt2c.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#cmt2c.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cmt2c.Pregnancy_Management"><h3>Pregnancy Management</h3><p>There is no registry or data regarding the frequency or outcome of pregnancies in women with a <i>TRPV4</i>-related disorder; however, the following general information may be reasonable to consider.</p><p>Ideally a woman with a <i>TRPV4</i>-associated disorder would seek consultation from a high-risk OB/GYN or maternal-fetal-medicine specialist to evaluate her risks for pregnancy and delivery.</p><p><b><i>TRPV4</i>-associated neuromuscular disorders.</b>
<a class="bk_pop" href="#cmt2c.REF.argov.2009.675">Argov &#x00026; de Visser [2009]</a> reviewed pregnancy issues in hereditary neuromuscular disorders including CMTs.</p><p>About 50% of women with CMT described increased weakness during pregnancy that usually resolved postpartum [<a class="bk_pop" href="#cmt2c.REF.rudniksch_neborn.1993.2011">Rudnik-Sch&#x000f6;neborn et al 1993</a>].</p><p>Operative deliveries were reported more commonly in women with CMT in Norway [<a class="bk_pop" href="#cmt2c.REF.hoff.2005.459">Hoff et al 2005</a>]. <a class="bk_pop" href="#cmt2c.REF.greenwood.2007.149">Greenwood &#x00026; Scott [2007]</a> described the obstetric approach to women with mild and severe forms of CMT.</p><p>A recent German study reviewed 63 pregnancies in 33 women with CMT [<a class="bk_pop" href="#cmt2c.REF.awater.2012.153">Awater et al 2012</a>] and found no increase in the frequency of cesarean section, forceps delivery, premature birth, or neonatal problems. About one third of mothers felt a worsening of CMT symptoms during pregnancy; in one fifth of mothers the changes were felt to be persistent.</p><p><b><i>TRPV4</i>-associated skeletal dysplasias.</b> In <i>TRPV4</i>-associated skeletal dysplasias, the degree of pulmonary compromise (from the short trunk and decreased lung capacity) may affect the ability to carry a pregnancy to term. Thus, it is unlikely a woman with metatropic dysplasia could carry a pregnancy.</p><p>A pregnant woman with a TRPV4-associated skeletal dysplasia generally undergo c&#x000e6;sarean section delivery because of the small size of the pelvis.</p></div><div id="cmt2c.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div><div id="cmt2c.Other"><h3>Other</h3><p>Career and employment choices may be influenced by persistent weakness of hands and/or feet.</p></div></div><div id="cmt2c.Genetic_Counseling"><h2 id="_cmt2c_Genetic_Counseling_">Genetic Counseling</h2><div id="cmt2c.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>TRPV4</i>-associated disorders (<i>TRPV4</i>-associated neuromuscular and skeletal disorders) are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="cmt2c.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with a <i>TRPV4</i>-associated disorder have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. However, since the most severe skeletal phenotypes can be lethal in childhood (or in utero), children with these phenotypes likely have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and unaffected parents.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <i>TRPV4</i>-associated disorder may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. <i>De novo</i> mutation is likely in children with severe, lethal presentations of <i>TRPV4</i>-associated disorders.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, two possible explanations are a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Although no instances of germline mosaicism have been reported, it remains a possibility.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include <i>TRPV4</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Evaluation of parents may determine that one is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> but has escaped previous diagnosis because of a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> or reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in the parent with the pathogenic variant. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</div></li></ul><p>Note: Although most individuals diagnosed with a <i>TRPV4</i>-associated disorder have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has a <i>TRPV4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li><li class="half_rhythm"><div>The sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinically unaffected parents are still at increased risk for a <i>TRPV4</i>-associated disorder because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in the parent with the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with a <i>TRPV4</i>-associated disorder has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Specific <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, age of onset, and disease severity cannot be predicted accurately because of incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a>. However, in general, a child who inherits a <i>TRPV4</i> pathogenic variant associated with neuromuscular disease or skeletal dysplasia from an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent is likely to have the same phenotype as the parent.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has a <i>TRPV4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="cmt2c.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>Because many individuals with short stature have reproductive partners with short stature, offspring of individuals with a <i>TRPV4</i>-associated skeletal disorder may be at risk of having double heterozygosity for two dominantly inherited bone growth disorders. The phenotypes of these individuals may be distinct from those of the parents. When the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> and the proband's reproductive partner are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with different dominantly inherited skeletal dysplasias, each child has a 25% likelihood of having average stature, a 25% likelihood of having the same skeletal dysplasia as the father, a 25% likelihood of having the same skeletal dysplasia as the mother, and a 25% likelihood of inheriting a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from both parents and being at risk for a potentially poor outcome.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant and/or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>Testing of at-risk asymptomatic adults.</b> Asymptomatic adults at risk of having inherited a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> with a <i>TRPV4</i>-associated disorder may wish to pursue <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. If identified to have inherited a <i>TRPV4</i> pathogenic variant, further clinical evaluation, EMG/NCV, and/or skeletal survey may be appropriate. No treatment is available to individuals early in the course of the disease. Thus, such testing is for personal decision making only.</p><p><b>Testing of at-risk asymptomatic individuals during childhood.</b> Testing of at-risk asymptomatic individuals who are younger than age 18 years should be considered on a case-by-case basis to determine if clinically appropriate. See also the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a>: ethical and policy issues in genetic testing and screening of children.</p><p><b>DNA banking</b> is the storage of DNA [typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cmt2c.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p>Once the <i>TRPV4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> for a <i>TRPV4</i>-associated disorder are possible. However, specific <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, age of onset, and/or disease severity cannot be reliably predicted based on the results of prenatal testing.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="cmt2c.Resources"><h2 id="_cmt2c_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><p>No specific resources for TRPV4-Associated Disorders have been identified by <i>GeneReviews</i> staff.</p></div><div id="cmt2c.Molecular_Genetics"><h2 id="_cmt2c_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cmt2c.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>TRPV4-Associated Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK201366/table/cmt2c.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2c.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cmt2c.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cmt2c.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cmt2c.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cmt2c.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cmt2c.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cmt2c.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cmt2c.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/59341" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TRPV4</i></a></td><td headers="hd_b_cmt2c.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=59341" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q24<wbr style="display:inline-block"></wbr>​.11</a></td><td headers="hd_b_cmt2c.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9HBA0" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Transient receptor potential cation channel subfamily V member 4</a></td><td headers="hd_b_cmt2c.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/TRPV4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TRPV4 database</a></td><td headers="hd_b_cmt2c.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TRPV4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TRPV4</a></td><td headers="hd_b_cmt2c.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TRPV4[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TRPV4</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cmt2c.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cmt2c.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for TRPV4-Associated Disorders (<a href="/omim/113500,156530,168400,181405,184095,184252,600175,605427,606071,606845" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK201366/table/cmt2c.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2c.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/113500" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">113500</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BRACHYOLMIA TYPE 3; BCYM3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/156530" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">156530</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METATROPIC DYSPLASIA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/168400" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">168400</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PARASTREMMATIC DWARFISM</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/181405" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">181405</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/184095" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">184095</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/184252" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">184252</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE; SMDK</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600175" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600175</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIII; HMN8</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605427" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605427</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 4; TRPV4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606071" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606071</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606845" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606845</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GOLGI-ASSOCIATED PDZ AND COILED-COIL DOMAINS-CONTAINING PROTEIN; GOPC</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>TRPV4</i> comprises 15 exons. Alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> may give rise to ten transcripts ranging from the 3,233-bp full-length transcript variant <a href="/nuccore/NM_021625.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_021625.4</a> that encodes 871 amino acids to smaller, alternatively spliced transcripts. The functional importance of smaller spliced <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> of <i>TRPV4</i> has not been established. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK201366/#cmt2c.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Variants p.Glu218Lys, p.Tyr567Ter, and p.Trp733Ter were found unlikely to be pathogenic due to lack of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <a class="def" href="/books/n/gene/glossary/def-item/segregation/">segregation</a>, lack of protein dysfunction, and lack of segregation and presence in controls, respectively [<a class="bk_pop" href="#cmt2c.REF.fawcett.2012.1204">Fawcett et al 2012</a>].</p><p><b>Pathogenic variants.</b> The authors are not aware of a whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or contiguous-gene <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>TRPV4</i> causing any of the recognized phenotypes.</p><ul><li class="half_rhythm"><div><b><i>TRPV4</i>-associated neuromuscular disorders.</b> Nine pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been reported. No frameshift or <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> pathogenic variants have been reported [<a class="bk_pop" href="#cmt2c.REF.zimo_.2010.1798">Zimo&#x00144; et al 2010</a>, <a class="bk_pop" href="#cmt2c.REF.mcentagart.2012.927">McEntagart 2012</a>].</div></li><li class="half_rhythm"><div><b><i>TRPV4</i>-associated skeletal dysplasias.</b> More than 40 pathogenic variants have been identified scattered throughout the protein. Three have been associated with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> digital arthropathy-brachydactyly (FDAB).</div></li></ul><div id="cmt2c.T.selected_trpv4_variants" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Selected <i>TRPV4</i> Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK201366/table/cmt2c.T.selected_trpv4_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2c.T.selected_trpv4_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Classification</th><th id="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predominant Phenotype</th><th id="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Benign</b></td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_2" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.652G&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu218Lys</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_5" rowspan="56" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_021625.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_021625<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_067638.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_067638<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1701C&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr567Ter</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2198G&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp733Ter</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_1" rowspan="53" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pathogenic</b></td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_2" rowspan="9" colspan="1" style="text-align:left;vertical-align:middle;">Neuromuscular</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.557G&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg186Gln</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.694C&#x0003e;T</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg232Cys&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.805C&#x0003e;T</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg269Cys</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.806G&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg269His</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.943C&#x0003e;T</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg315Trp</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.946C&#x0003e;T</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg316Cys</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.947G&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg316His</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1625C&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser542Tyr&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1858G&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val620Ile&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_2" rowspan="41" colspan="1" scope="row" style="text-align:left;vertical-align:middle;">Skeletal</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.82A&#x0003e;G</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys276Glu&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.232G&#x0003e;T</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly78Trp&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.266C&#x0003e;T</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr89Ile</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.547G&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu183Lys</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.590A&#x0003e;G</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys197Arg</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.597G&#x0003e;C</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu199Phe</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.649G&#x02009;&#x0003e;&#x02009;T</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala217Ser&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.717G&#x0003e;C</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln239His</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.832G&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu278Lys&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.883A&#x0003e;G</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr295Ala</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.991A&#x0003e;T</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile331Phe</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.992T&#x0003e;C</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile331Thr</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.998A&#x0003e;G</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp333Gly</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1024G&#x0003e;T</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val342Phe</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1219A&#x0003e;G</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys407Glu</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1412_1414delTCT</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe471del</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1566_1568dupCCT</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu523dup</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1772A&#x0003e;G</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr591Cys&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1774T&#x0003e;C</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe592Leu</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1781G&#x0003e;</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg594Ser</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1781G&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg594His&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1787T&#x0003e;C</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu596Pro</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1798G&#x0003e;T</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly600Trp</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1805A&#x0003e;G</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr602Cys</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1812C&#x0003e;G</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile604Met</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1847G&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg616Gln</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1851C&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe617Leu</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1853T&#x0003e;C</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p Leu618Pro</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1858G&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val620Ile</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1875G&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met625Ile</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2125C&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu709Met</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2146G&#x0003e;T</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala716Ser</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2219C&#x0003e;T</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr740Ile&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2330G&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys777Tyr</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2389G&#x0003e;A</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu797Lys&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2395C&#x0003e;T</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro799Ser</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2396C&#x02009;&#x0003e;&#x02009;</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro799Ala</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2396C&#x02009;&#x0003e;G</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro799Arg&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2396C&#x0003e;G</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro799Arg&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2396C&#x0003e;T</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro799Leu</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2396_2412del17</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro799LeufsTer63&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_2" rowspan="3" colspan="1" scope="row" style="text-align:left;vertical-align:middle;">Familial digital arthropathy-brachydactyly (FDAB)</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.809G&#x0003e;T</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly270Val</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.812G&#x0003e;C</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg271Pro</td></tr><tr><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.819C&#x0003e;G</td><td headers="hd_h_cmt2c.T.selected_trpv4_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe273Leu</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="cmt2c.TF.4.1"><p class="no_margin">Denotes a combined neuromuscular and skeletal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>TRPV4</i> encodes a non-selective cation channel modestly permeable to Ca2+ [<a class="bk_pop" href="#cmt2c.REF.liedtke.2000.525">Liedtke et al 2000</a>, <a class="bk_pop" href="#cmt2c.REF.plant.2007.189">Plant &#x00026; Strotmann 2007</a>]. TRPV4 was initially identified as a vertebrate osmosensor, but can be activated by a wide variety of stimuli including cell shearing, heat, endogenous agonists (e.g., endocannabinoid anandamide, arachidonic acid), and synthetic agonists like 4_-phorbol-12,13-didecanoate (4_PDD) [<a class="bk_pop" href="#cmt2c.REF.liedtke.2000.525">Liedtke et al 2000</a>, <a class="bk_pop" href="#cmt2c.REF.nilius.2003.298">Nilius et al 2003</a>, <a class="bk_pop" href="#cmt2c.REF.watanabe.2003.434">Watanabe et al 2003</a>, <a class="bk_pop" href="#cmt2c.REF.plant.2007.189">Plant &#x00026; Strotmann 2007</a>, <a class="bk_pop" href="#cmt2c.REF.everaerts.2010.2">Everaerts et al 2010</a>].</p><p>TRPV4 is expressed broadly and has diverse physiologic roles, including in osmosensation and flow sensing in the kidney [<a class="bk_pop" href="#cmt2c.REF.pochynyuk.2013.177">Pochynyuk et al 2013</a>], mechanosensation and nociception in the sensory nervous system [<a class="bk_pop" href="#cmt2c.REF.suzuki.2003.22664">Suzuki et al 2003</a>, <a class="bk_pop" href="#cmt2c.REF.alessandrihaber.2009.6217">Alessandri-Haber et al 2009</a>], stretch sensation in the bladder [<a class="bk_pop" href="#cmt2c.REF.gevaert.2007.3453">Gevaert et al 2007</a>], skin barrier function [<a class="bk_pop" href="#cmt2c.REF.kida.2012.715">Kida et al 2012</a>], chondrogenesis [<a class="bk_pop" href="#cmt2c.REF.muramatsu.2007.32158">Muramatsu et al 2007</a>], bone homeostasis [<a class="bk_pop" href="#cmt2c.REF.masuyama.2012.1708">Masuyama et al 2012</a>], and regulation of adipose oxidative metabolism [<a class="bk_pop" href="#cmt2c.REF.ye.2012.96">Ye et al 2012</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> While the exact pathophysiology of <i>TRPV4</i> pathogenic variants that result in neuromuscular disease is unknown, several hypotheses exist. (Note: The use of various cell systems in the following studies may underlie the differences in results [<a class="bk_pop" href="#cmt2c.REF.nilius.2010.98">Nilius &#x00026; Owsianik 2010</a>].)</p><ul><li class="half_rhythm"><div>In one study, three <i>TRPV4</i> pathogenic variants (p.Arg269His, p.Arg315Trp, and p.Arg316Cys) influenced proper localization of the mutated protein ion channel to the plasma membrane [<a class="bk_pop" href="#cmt2c.REF.auergrumbach.2010.160">Auer-Grumbach et al 2010</a>] with the formation of cytoplasmic aggregates. Mutated TRPV4 was shown to cause loss of normal channel function [<a class="bk_pop" href="#cmt2c.REF.auergrumbach.2010.160">Auer-Grumbach et al 2010</a>].</div></li><li class="half_rhythm"><div>The results from two other studies differed substantially [<a class="bk_pop" href="#cmt2c.REF.deng.2010.165">Deng et al 2010</a>, <a class="bk_pop" href="#cmt2c.REF.landour_.2010.170">Landour&#x000e9; et al 2010</a>]: both showed increased intracellular calcium levels caused by abnormal activity of the TRPV4 ion channel in the presence of the p.Arg269His, p.Arg269Cys, or p.Arg316Cys <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul><p>Similarly the exact pathophysiology of <i>TRPV4</i> pathogenic variants that result in skeletal dysplasia is not well understood. Based on the lack of a comparable <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in the <i>Trpv4</i> knockout mouse, it is presumed that the mechanism of disease in humans is by dominant gain of function. This mechanism also fits with the vast majority of the known <i>TRPV4</i> pathogenic variants being <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>; however, an <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> that adds an extra leucine in the second transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> has also been described. Nevertheless, exceptions exist, such as the single frameshift <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> variant shown in <a class="figpopup" href="/books/NBK201366/table/cmt2c.T.selected_trpv4_variants/?report=objectonly" target="object" rid-figpopup="figcmt2cTselectedtrpv4variants" rid-ob="figobcmt2cTselectedtrpv4variants">Table 4</a>.</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is expressed in osteoblasts and osteoclasts at the earliest stages of chondrocyte differentiation &#x02013; a finding that is consistent with its role in these skeletal disorders. A recent study by <a class="bk_pop" href="#cmt2c.REF.nilius.2013.152">Nilius &#x00026; Voets [2013]</a> showed that the single nucleotide variants p.Arg616Gln and p.Val620Ile result in a gain of function characterized by increased constitutive activity and elevated channel activation.</p></div><div id="cmt2c.References"><h2 id="_cmt2c_References_">References</h2><div id="cmt2c.Published_Guidelines__Consensus_St"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF1">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2013. Accessed 12-9-19. [<a href="/pubmed/23428972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23428972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF2">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2018. Accessed 12-9-19.</div></li></ul></div><div id="cmt2c.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.argov.2009.675">Argov Z, de Visser M. What we do not know about pregnancy in hereditary neuromuscular disorders. <span><span class="ref-journal">Neuromuscul Disord. </span>2009;<span class="ref-vol">19</span>:675–9.</span> [<a href="/pubmed/19692244" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19692244</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.alessandrihaber.2009.6217">Alessandri-Haber N, Dina OA, Chen X, Levine JD. TRPC1 and TRPC6 channels cooperate with TRPV4 to mediate mechanical hyperalgesia and nociceptor sensitization. <span><span class="ref-journal">J Neurosci. </span>2009;<span class="ref-vol">29</span>:6217–28.</span> [<a href="/pmc/articles/PMC2726836/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2726836</span></a>] [<a href="/pubmed/19439599" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19439599</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.amor.2002.235">Amor DJ, Tudball C, Gardner RJ, Lamand&#x000e9; SR, Bateman JF, Savarirayan R. Familial digital arthropathy-brachydactyly. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">108</span>:235–40.</span> [<a href="/pubmed/11891693" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11891693</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.astrea.2012.364">Astrea G, Brisca G, Fiorillo C, Valle M, Tosetti M, Bruno C, Santorelli FM, Battini R. Muscle MRI in TRPV4-related congenital distal SMA. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">78</span>:364–5.</span> [<a href="/pubmed/22291064" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22291064</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.auergrumbach.2010.160">Auer-Grumbach M, Olschewski A, Papi&#x00107; L, Kremer H, McEntagart ME, Uhrig S, Fischer C, Fr&#x000f6;hlich E, B&#x000e1;lint Z, Tang B, Strohmaier H, Lochm&#x000fc;ller H, Schlotter-Weigel B, Senderek J, Krebs A, Dick KJ, Petty R, Longman C, Anderson NE, Padberg GW, Schelhaas HJ, van Ravenswaaij-Arts CM, Pieber TR, Crosby AH, Guelly C. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:160–4.</span> [<a href="/pmc/articles/PMC3272392/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3272392</span></a>] [<a href="/pubmed/20037588" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20037588</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.auergrumbach.2005.415">Auer-Grumbach M, Schlotter-Weigel B, Lochm&#x000fc;ller H, Strobl-Wildemann G, Auer-Grumbach P, Fischer R, Offenbacher H, Zwick EB, Robl T, Hartl G, Hartung HP, Wagner K, Windpassinger C, et al.  Phenotypes of the N88S Berardinelli-Seip congenital lipodystrophy 2 mutation. <span><span class="ref-journal">Ann Neurol. </span>2005;<span class="ref-vol">57</span>:415–24.</span> [<a href="/pubmed/15732094" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15732094</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.awater.2012.153">Awater C, Zerres K, Rudnik-Sch&#x000f6;neborn S. Pregnancy course and outcome in women with hereditary neuromuscular disorders: comparison of obstetric risks in 178 patients. <span><span class="ref-journal">Eur J Obstet Gynecol Reprod Biol. </span>2012;<span class="ref-vol">162</span>:153–9.</span> [<a href="/pubmed/22459654" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22459654</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.barwick.2012.1103">Barwick KE, Wright J, Al-Turki S, McEntagart MM, Nair A, Chioza B, Al-Memar A, Modarres H, Reilly MM, Dick KJ, Ruggiero AM, Blakely RD, Hurles ME, Crosby AH. Defective presynaptic choline transport underlies hereditary motor neuropathy. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">91</span>:1103–7.</span> [<a href="/pmc/articles/PMC3516609/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3516609</span></a>] [<a href="/pubmed/23141292" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23141292</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.beck.1983.231">Beck M, Roubicek M, Rogers JG, Naumoff P, Spranger J. Heterogeneity of metatropic dysplasia. <span><span class="ref-journal">Europ J Pediat. </span>1983;<span class="ref-vol">140</span>:231–7.</span> [<a href="/pubmed/6628444" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6628444</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.berciano.2011.1413">Berciano J, Baets J, Gallardo E, Zimon M, Garcia A, Lopez-Laso E, Combarros O, Infante J, Timmerman V, Jordanova A, De Jonghe P. Reduced penetrance in hereditary motor neuropathy caused by TRPV4 arg269-to-cys mutation. <span><span class="ref-journal">J Neurol. </span>2011;<span class="ref-vol">258</span>:1413–21.</span> [<a href="/pubmed/21336783" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21336783</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.chen.2010.1968">Chen DH, Sul Y, Weiss M, Hillel A, Lipe H, Wolff J, Matsushita M, Raskind W, Bird T. CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene. <span><span class="ref-journal">Neurology. </span>2010;<span class="ref-vol">75</span>:1968–75.</span> [<a href="/pmc/articles/PMC3014233/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3014233</span></a>] [<a href="/pubmed/21115951" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21115951</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.cho.2012.795">Cho TJ, Matsumoto K, Fano V, Dai J, Kim OH, Chae JH, Yoo WJ, Tanaka Y, Matsui Y, Takigami I, Monges S, Zabel B, Shimizu K, Nishimura G, Lausch E, Ikegawa S. TRPV4-pathy manifesting both skeletal dysplasia and peripheral neuropathy: a report of three patients. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:795–802.</span> [<a href="/pubmed/22419508" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22419508</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.dai.2010.704">Dai J, Kim OH, Cho TJ, Schmidt-Rimpler M, Tonoki H, Takikawa K, Haga N, Miyoshi K, Kitoh H, Yoo WJ, Choi IH, Song HR, Jin DK, Kim HT, Kamasaki H, Bianchi P, Grigelioniene G, Nampoothiri S, Minagawa M, Miyagawa SI, Fukao T, Marcelis C, Jansweijer MC, Hennekam RC, Bedeschi F, Mustonen A, Jiang Q, Ohashi H, Furuichi T, Unger S, Zabel B, Lausch E, Superti-Furga A, Nishimura G, Ikegawa S. Novel and recurrent TRPV4 mutations and their association with distinct phenotypes within the TRPV4 dysplasia family. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:704–9.</span> [<a href="/pubmed/20577006" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20577006</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.delong.1992.905">DeLong R, Siddique T. A large New England kindred with autosomal dominant neurogenic scapuloperoneal amyotrophy with unique features. <span><span class="ref-journal">Arch Neurol. </span>1992;<span class="ref-vol">49</span>:905–8.</span> [<a href="/pubmed/1520078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1520078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.deng.2010.165">Deng H-X, Klein CJ, Yan J, Shi Y, Wu Y, Fecto F, Yau H-J, Yang Y, Zhai H, Siddique N, Hedley-Whyte ET, DeLong R, Martina M, Dyck PJ, Siddique T. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:165–9.</span> [<a href="/pmc/articles/PMC3786192/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3786192</span></a>] [<a href="/pubmed/20037587" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20037587</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.de_jonghe.1999.281">De Jonghe P, Timmerman V, Ceuterick C, Nelis E, De Vriendt E, L&#x000f6;fgren A, Vercruyssen A, Verellen C, Van Maldergem L, Martin JJ, Van Broeckhoven C. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. <span><span class="ref-journal">Brain. </span>1999;<span class="ref-vol">122</span>:281–90.</span> [<a href="/pubmed/10071056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10071056</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.donaghy.1999.552">Donaghy M, Kennett R. Varying occurrence of vocal cord paralysis in a family with autosomal dominant hereditary motor and sensory neuropathy. <span><span class="ref-journal">J Neurol. </span>1999;<span class="ref-vol">246</span>:552–5.</span> [<a href="/pubmed/10463355" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10463355</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.dyck.1994.608">Dyck PJ, Litchy WJ, Minnerath S, Bird TD, Chance PF, Schaid DJ, Aronson AE. Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. <span><span class="ref-journal">Ann Neurol. </span>1994;<span class="ref-vol">35</span>:608–15.</span> [<a href="/pubmed/8179305" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8179305</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.everaerts.2010.2">Everaerts W, Nilius B, Owsianik G. The vanilloid transient receptor potential channel TRPV4: from structure to disease. <span><span class="ref-journal">Prog Biophys Mol Biol. </span>2010;<span class="ref-vol">103</span>:2–17.</span> [<a href="/pubmed/19835908" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19835908</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.fawcett.2012.1204">Fawcett KA, Murphy SM, Polke JM, Wray S, Burchell VS, Manji H, Quinlivan RM, Zdebik AA, Reilly MM, Houlden H. Comprehensive analysis of the TRPV4 gene in a large series of inherited neuropathies and controls. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2012;<span class="ref-vol">83</span>:1204–9.</span> [<a href="/pubmed/22851605" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22851605</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.fiorillo.2012.195">Fiorillo C, Moro F, Brisca G, Astrea G, Nesti C, B&#x000e1;lint Z, Olschewski A, Meschini MC, Guelly C, Auer-Grumbach M, Battini R, Pedemonte M, Romano A, Menchise V, Biancheri R, Santorelli FM, Bruno C. TRPV4 mutations in children with congenital distal spinal muscular atrophy. <span><span class="ref-journal">Neurogenetics. </span>2012;<span class="ref-vol">13</span>:195–203.</span> [<a href="/pubmed/22526352" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22526352</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.gemignani.2004.7">Gemignani F, Melli G, Alfieri S, Inglese C, Marbini A. Sensory manifestations in Charcot-Marie-Tooth disease. <span><span class="ref-journal">J Peripher Nerv Syst. </span>2004;<span class="ref-vol">9</span>:7–14.</span> [<a href="/pubmed/14871449" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14871449</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.gevaert.2007.3453">Gevaert T, Vriens J, Segal A, Everaerts W, Roskams T, Talavera K, Owsianik G, Liedtke W, Daelemans D, Dewachter I, Van Leuven F, Voets T, De Ridder D, Nilius B. Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. <span><span class="ref-journal">J Clin Invest. </span>2007;<span class="ref-vol">117</span>:3453–62.</span> [<a href="/pmc/articles/PMC2030459/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2030459</span></a>] [<a href="/pubmed/17948126" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17948126</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.grandis.2005.23">Grandis M, Shy ME. Current therapy for Charcot-Marie-Tooth disease. <span><span class="ref-journal">Curr Treat Options Neurol. </span>2005;<span class="ref-vol">7</span>:23–31.</span> [<a href="/pubmed/15610704" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15610704</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.greenwood.2007.149">Greenwood JJ, Scott WE. Charcot-Marie-Tooth disease: peripartum management of two contrasting clinical cases. <span><span class="ref-journal">Int J Obstet Anesth. </span>2007;<span class="ref-vol">16</span>:149–54.</span> [<a href="/pubmed/17275278" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17275278</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.guyton.2000.317">Guyton GP, Mann RA. The pathogenesis and surgical management of foot deformity in Charcot-Marie-Tooth disease. <span><span class="ref-journal">Foot Ankle Clin. </span>2000;<span class="ref-vol">5</span>:317–26.</span> [<a href="/pubmed/11232233" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11232233</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.hall.2004.66">Hall CM, Elcioglu NH. Metatropic dysplasia lethal variants. <span><span class="ref-journal">Pediatr Radiol. </span>2004;<span class="ref-vol">34</span>:66–74.</span> [<a href="/pubmed/14566438" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14566438</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.hoff.2005.459">Hoff JM, Gilhus NE, Daltveit AK. Pregnancies and deliveries in patients with Charcot-Marie-Tooth disease. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:459–62.</span> [<a href="/pubmed/15699375" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15699375</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.kannu.2007.2512">Kannu P, Aftimos S, Mayne V, Donnan L, Savarirayan R. Metatropic dysplasia: clinical and radiographic findings in 11 patients demonstrating long-term natural history. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:2512–22.</span> [<a href="/pubmed/17879966" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17879966</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.kida.2012.715">Kida N, Sokabe T, Kashio M, Haruna K, Mizuno Y, Suga Y, Nishikawa K, Kanamaru A, Hongo M, Oba A, Tominaga M. Importance of transient receptor potential vanilloid 4 (TRPV4) in epidermal barrier function in human skin keratinocytes. <span><span class="ref-journal">Pfl&#x000fc;gers Arch. </span>2012;<span class="ref-vol">463</span>:715–25.</span> [<a href="/pubmed/22374181" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22374181</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.krakow.2009.307">Krakow D, Vriens J, Camacho N, Luong P, Deixler H, Funari TL, Bacino CA, Irons MB, Holm IA, Sadler L, Okenfuss EB, Janssens A, Voets T, Rimoin DL, Lachman RS, Nilius B, Cohn DH. Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia. <span><span class="ref-journal">Am J Hum Genet. </span>2009;<span class="ref-vol">84</span>:307–15.</span> [<a href="/pmc/articles/PMC2667978/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2667978</span></a>] [<a href="/pubmed/19232556" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19232556</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.landour_.2010.170">Landour&#x000e9; G, Zdebik AA, Martinez TL, Burnett BG, Stanescu HC, Inada H, Shi Y, Taye AA, Kong L, Munns CH, Choo SS, Phelps CB, Paudel R, Houlden H, Ludlow CL, Caterina MJ, Gaudet R, Kleta R, Fischbeck KH, Sumner CJ. Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:170–4.</span> [<a href="/pmc/articles/PMC2812627/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2812627</span></a>] [<a href="/pubmed/20037586" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20037586</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.liedtke.2000.525">Liedtke W, Choe Y, Marti-Renom MA, Bell AM, Denis CS, Sali A, Hudspeth AJ, Friedman JM, Heller S. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. <span><span class="ref-journal">Cell. </span>2000;<span class="ref-vol">103</span>:525–35.</span> [<a href="/pmc/articles/PMC2211528/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2211528</span></a>] [<a href="/pubmed/11081638" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11081638</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.maroteaux.1966.211">Maroteaux P, Spranger J, Wiedemann HR. Metatropische Zwergwuchs. <span><span class="ref-journal">Arch Kinderheil. </span>1966;<span class="ref-vol">173</span>:211.</span> [<a href="/pubmed/4963592" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4963592</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.masuyama.2012.1708">Masuyama R, Mizuno A, Komori H, Kajiya H, Uekawa A, Kitaura H, Okabe K, Ohyama K, Komori T. Calcium/calmodulin-signaling supports TRPV4 activation in osteoclasts and regulates bone mass. <span><span class="ref-journal">J Bone Miner Res. </span>2012;<span class="ref-vol">27</span>:1708–21.</span> [<a href="/pubmed/22492541" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22492541</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.mcentagart.2012.927">McEntagart M. TRPV4 axonal neuropathy spectrum disorder. <span><span class="ref-journal">J Clin Neurosci. </span>2012;<span class="ref-vol">19</span>:927–33.</span> [<a href="/pubmed/22617546" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22617546</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.mcentagart.2001.1270">McEntagart M, Norton N, Williams H, Teare MD, Dunstan M, Baker P, Houlden H, Reilly M, Wood N, Harper PS, Futreal PA, Williams N, Rahman N. Localization of the gene for distal hereditary motor neuronopathy VII (dHMN-VII) to chromosome 2q14. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">68</span>:1270–6.</span> [<a href="/pmc/articles/PMC1226107/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1226107</span></a>] [<a href="/pubmed/11294660" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11294660</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.mcentagart.2005.293">McEntagart ME, Reid SL, Irrthum A, Douglas JB, Eyre KE, Donaghy MJ, Anderson NE, Rahman N. Confirmation of a hereditary motor and sensory neuropathy IIC locus at chromosome 12q23-q24. <span><span class="ref-journal">Ann Neurol. </span>2005;<span class="ref-vol">57</span>:293–7.</span> [<a href="/pubmed/15668982" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15668982</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.muramatsu.2007.32158">Muramatsu S, Wakabayashi M, Ohno T, Amano K, Ooishi R, Sugahara T, Shiojiri S, Tashiro K, Suzuki Y, Nishimura R, Kuhara S, Sugano S, Yoneda T, Matsuda A. Functional gene screening system identified TRPV4 as a regulator of chondrogenic differentiation. <span><span class="ref-journal">J Biol Chem. </span>2007;<span class="ref-vol">282</span>:32158–67.</span> [<a href="/pubmed/17804410" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17804410</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.nemec.2012.15">Nemec SF, Cohn DH, Krakow D, Funari VA, Rimoin DL, Lachman RS. The importance of conventional radiography in the mutational analysis of skeletal dysplasias (the TRPV4 mutational family). <span><span class="ref-journal">Pediatr Radiol. </span>2012;<span class="ref-vol">42</span>:15–23.</span> [<a href="/pubmed/21863289" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21863289</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.nilius.2010.98">Nilius B, Owsianik G. Channelopathies converge on TRPV4. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:98–100.</span> [<a href="/pubmed/20104247" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20104247</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.nilius.2013.152">Nilius B, Voets T. The puzzle of TRPV4 channelopathies. <span><span class="ref-journal">EMBO Rep. </span>2013;<span class="ref-vol">14</span>:152–63.</span> [<a href="/pmc/articles/PMC3566843/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3566843</span></a>] [<a href="/pubmed/23306656" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23306656</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.nilius.2003.298">Nilius B, Watanabe H, Vriens J. The TRPV4 channel: structure-function relationship and promiscuous gating behaviour. <span><span class="ref-journal">Pflugers Arch. </span>2003;<span class="ref-vol">446</span>:298–303.</span> [<a href="/pubmed/12715179" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12715179</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.nishimura.2012.190">Nishimura G, Lausch E, Savarirayan R, Shiba M, Spranger J, Zabel B, Ikegawa S, Superti-Furga A, Unger S. TRPV4-associated skeletal dysplasias. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2012;<span class="ref-vol">160C</span>:190–204.</span> [<a href="/pubmed/22791502" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22791502</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.oates.2012.1714">Oates EC, Reddel S, Rodriguez ML, Gandolfo LC, Bahlo M, Hawke SH, Lamand&#x000e9; SR, Clarke NF, North KN. Autosomal dominant congenital spinal muscular atrophy: a true form of spinal muscular atrophy caused by early loss of anterior horn cells. <span><span class="ref-journal">Brain. </span>2012;<span class="ref-vol">135</span>:1714–23.</span> [<a href="/pubmed/22628388" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22628388</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.padua.2006.417">Padua L, Aprile I, Cavallaro T, Commodari I, La Torre G, Pareyson D, Quattrone A, Rizzuto N, Vita G, Tonali P, Schenone A, Italian CMT. Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study. <span><span class="ref-journal">Neurol Sci. </span>2006;<span class="ref-vol">27</span>:417–23.</span> [<a href="/pubmed/17205227" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17205227</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.pochynyuk.2013.177">Pochynyuk O, Zaika O, O'Neil RG, Mamenko M. Novel insights into TRPV4 function in the kidney. <span><span class="ref-journal">Pfl&#x000fc;gers Arch. </span>2013;<span class="ref-vol">465</span>:177–86.</span> [<a href="/pmc/articles/PMC3562383/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3562383</span></a>] [<a href="/pubmed/23207579" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23207579</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.plant.2007.189">Plant TD, Strotmann R. TRPV4. <span><span class="ref-journal">Handb Exp Pharmacol. </span>2007;<span class="ref-vol">179</span>:189–205.</span> [<a href="/pubmed/17217058" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17217058</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.puls.2003.455">Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Mann E, Floeter MK, Bidus K, Drayna D, Oh SJ, Brown RH, Ludlow CL, Fischbeck KH. Mutant dynactin in motor neuron disease. <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">33</span>:455–6.</span> [<a href="/pubmed/12627231" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12627231</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.rock.2008.999">Rock MJ, Prenen J, Funari VA, Funari TL, Merriman B, Nelson SF, Lachman RS, Wilcox WR, Reyno S, Quadrelli R, Vaglio A, Owsianik G, Janssens A, Voets T, Ikegawa S, Nagai T, Rimoin DL, Nilius B, Cohn DH. Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:999–1003.</span> [<a href="/pmc/articles/PMC3525077/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3525077</span></a>] [<a href="/pubmed/18587396" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18587396</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.rossor.2012.6">Rossor AM, Kalmar B, Greensmith L, Reilly MM. The distal hereditary motor neuropathies. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2012;<span class="ref-vol">83</span>:6–14.</span> [<a href="/pubmed/22028385" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22028385</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.rudniksch_neborn.1993.2011">Rudnik-Sch&#x000f6;neborn S, R&#x000f6;hrig D, Nicholson G, Zerres K. Pregnancy and delivery in Charcot-Marie-Tooth disease type 1. <span><span class="ref-journal">Neurology. </span>1993;<span class="ref-vol">43</span>:2011–6.</span> [<a href="/pubmed/8413959" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8413959</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.santoro.2002.399">Santoro L, Manganelli F, Di Maio L, Barbieri F, Carella M, D'Adamo P, Casari G. Charcot-Marie-Tooth disease type 2C: a distinct genetic entity. Clinical and molecular characterization of the first European family. <span><span class="ref-journal">Neuromuscul Disord. </span>2002;<span class="ref-vol">12</span>:399–404.</span> [<a href="/pubmed/12062259" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12062259</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.sivakumar.2005.2304">Sivakumar K, Kyriakides T, Puls I, Nicholson GA, Funalot B, Antonellis A, Sambuughin N, Christodoulou K, Beggs JL, Zamba-Papanicolaou E, Ionasescu V, Dalakas MC, Green ED, Fischbeck KH, Goldfarb LG. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. <span><span class="ref-journal">Brain. </span>2005;<span class="ref-vol">128</span>:2304–14.</span> [<a href="/pubmed/16014653" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16014653</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.sullivan.2013.c999">Sullivan MN, Earley S. TRP channel Ca(2+) sparklets: fundamental signals underlying endothelium-dependent hyperpolarization. <span><span class="ref-journal">Am J Physiol Cell Physiol. </span>2013;<span class="ref-vol">305</span>:C999–C1008.</span> [<a href="/pmc/articles/PMC3840200/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3840200</span></a>] [<a href="/pubmed/24025865" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24025865</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.suzuki.2003.22664">Suzuki M, Mizuno A, Kodaira K, Imai M. Impaired pressure sensation in mice lacking TRPV4. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:22664–8.</span> [<a href="/pubmed/12692122" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12692122</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.unger.2011.2860">Unger S, Lausch E, Stanzial F, Gillessen-Kaesbach G, Stefanova I, Di Stefano CM, Bertini E, Dionisi-Vici C, Nilius B, Zabel B, Superti-Furga A. Fetal akinesia in metatropic dysplasia: the combined phenotype of chondrodysplasia and neuropathy? <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:2860–4.</span> [<a href="/pubmed/21964829" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21964829</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.vlam.2012.790">Vlam L, Schelhaas HJ, van Blitterswijk M, van Vught PW, de Visser M, van der Kooi AJ, van der Pol WL, van den Berg LH. Mutations in the TRPV4 gene are not associated with sporadic progressive muscular atrophy. <span><span class="ref-journal">Arch Neurol. </span>2012;<span class="ref-vol">69</span>:790–1.</span> [<a href="/pubmed/22689196" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22689196</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.watanabe.2003.434">Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. <span><span class="ref-journal">Nature. </span>2003;<span class="ref-vol">424</span>:434–8.</span> [<a href="/pubmed/12879072" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12879072</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.ye.2012.96">Ye L, Kleiner S, Wu J, Sah R, Gupta RK, Banks AS, Cohen P, Khandekar MJ, Bostr&#x000f6;m P, Mepani RJ, Laznik D, Kamenecka TM, Song X, Liedtke W, Mootha VK, Puigserver P, Griffin PR, Clapham DE, Spiegelman BM. TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis. <span><span class="ref-journal">Cell. </span>2012;<span class="ref-vol">151</span>:96–110.</span> [<a href="/pmc/articles/PMC3477522/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3477522</span></a>] [<a href="/pubmed/23021218" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23021218</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2c.REF.zimo_.2010.1798">Zimo&#x00144; M, Baets J, Berciano J, Garcia A, Lopez-Laso E, Merlini L, Hilton-Jones D, McEntagart M, Crosby AH, Barisic N, Boltshauser E, Shaw CE, Landour&#x000e9; G, Ludlow CL, Gaudet R, Houlden H, Reilly MM, Fischbeck KH, Sumner CJ, Timmerman V, Jordanova A, Jonghe PD. Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies. <span><span class="ref-journal">Brain. </span>2010;<span class="ref-vol">133</span>:1798–809.</span> [<a href="/pmc/articles/PMC2912694/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2912694</span></a>] [<a href="/pubmed/20460441" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20460441</span></a>]</div></li></ul></div></div><div id="cmt2c.Chapter_Notes"><h2 id="_cmt2c_Chapter_Notes_">Chapter Notes</h2><div id="cmt2c.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>15 May 2014 (me) Review posted live</div></li><li class="half_rhythm"><div>30 July 2013 (as) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK201366</span><span class="label">PMID: <a href="/pubmed/24830047" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">24830047</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/trio-id/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pc-hypo-p/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK201366&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK201366/?report=reader">PubReader</a></li><li><a href="/books/NBK201366/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK201366" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK201366" style="display:none" title="Cite this Page"><div class="bk_tt">Schindler A, Sumner C, Hoover-Fong JE. TRPV4-Associated Disorders. 2014 May 15. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK201366/pdf/Bookshelf_NBK201366.pdf">PDF version of this page</a> (536K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cmt2c.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cmt2c.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#cmt2c.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cmt2c.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cmt2c.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#cmt2c.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cmt2c.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cmt2c.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cmt2c.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cmt2c.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cmt2c.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cmt2c.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=59341[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TRPV4</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=3094004" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3094004" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3094004" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=3094004" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22791502" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> TRPV4-associated skeletal dysplasias.</a><span class="source">[Am J Med Genet C Semin Med Gen...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> TRPV4-associated skeletal dysplasias.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nishimura G, Lausch E, Savarirayan R, Shiba M, Spranger J, Zabel B, Ikegawa S, Superti-Furga A, Unger S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet C Semin Med Genet. 2012 Aug 15; 160C(3):190-204. Epub 2012 Jul 12.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301472" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">COL1A1/2</i> Osteogenesis Imperfecta</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">COL1A1/2</i> Osteogenesis Imperfecta<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Steiner RD, Basel D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20505684" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> TRPV4-pathy, a novel channelopathy affecting diverse systems.</a><span class="source">[J Hum Genet. 2010]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> TRPV4-pathy, a novel channelopathy affecting diverse systems.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dai J, Cho TJ, Unger S, Lausch E, Nishimura G, Kim OH, Superti-Furga A, Ikegawa S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Hum Genet. 2010 Jul; 55(7):400-2. Epub 2010 May 27.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31191204" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Combined Phenotypes of Spondylometaphyseal Dysplasia-Kozlowski Type and Charcot-Marie-Tooth Disease Type 2C Secondary to a TRPV4 Pathogenic Variant.</a><span class="source">[Mol Syndromol. 2019]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Combined Phenotypes of Spondylometaphyseal Dysplasia-Kozlowski Type and Charcot-Marie-Tooth Disease Type 2C Secondary to a TRPV4 Pathogenic Variant.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Faye E, Modaff P, Pauli R, Legare J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Syndromol. 2019 May; 10(3):154-160. Epub 2018 Dec 21.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20614582" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">DNM2</i>-Related Intermediate Charcot-Marie-Tooth Neuropathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">DNM2</i>-Related Intermediate Charcot-Marie-Tooth Neuropathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Züchner S, Tao F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=24830047" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=24830047" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc957cdd21425a2507bb93">TRPV4-Associated Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">TRPV4-Associated Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:33:48-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89F52EDFC84FB100000000085A03DB&amp;ncbi_session=CE89F52EDFC957B1_2138SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK201366%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK201366&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK201366/&amp;ncbi_pagename=TRPV4-Associated Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89F52EDFC957B1_2138SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>